<html class="gs_el_sm gs_pfcs"><head><title>‪Mary Frances McMullin‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=beoArAkAAAAJ&amp;hl=en"><meta name="description" content="‪Queens university Belfast‬ - ‪‪Cited by 14,878‬‬"><meta property="og:description" content="‪Queens university Belfast‬ - ‪‪Cited by 14,878‬‬"><meta property="og:title" content="Mary Frances McMullin"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"zZ1AYdKRK8i1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=beoArAkAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUHvTYLMESFMlxSXEBkVPiq4VwPGQtG9"><input type="hidden" name="user" value="beoArAkAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">14878</td><td class="gsc_rsb_std">7392</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">59</td><td class="gsc_rsb_std">45</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">169</td><td class="gsc_rsb_std">115</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:742px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:696px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">1400</div><div class="gsc_g_xtl" style="top:73px;">700</div><div class="gsc_g_xtl" style="top:113px;">350</div><div class="gsc_g_xtl" style="top:33px;">1050</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:156px;height:4px;z-index:21"><span class="gsc_g_al">40</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:156px;height:4px;z-index:20"><span class="gsc_g_al">37</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:154px;height:6px;z-index:19"><span class="gsc_g_al">58</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:149px;height:11px;z-index:18"><span class="gsc_g_al">99</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:149px;height:11px;z-index:17"><span class="gsc_g_al">104</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:142px;height:18px;z-index:16"><span class="gsc_g_al">164</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:129px;height:31px;z-index:15"><span class="gsc_g_al">274</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:108px;height:52px;z-index:14"><span class="gsc_g_al">455</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:105px;height:55px;z-index:13"><span class="gsc_g_al">483</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:98px;height:62px;z-index:12"><span class="gsc_g_al">544</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:78px;height:82px;z-index:11"><span class="gsc_g_al">718</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:62px;height:98px;z-index:10"><span class="gsc_g_al">859</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:48px;height:112px;z-index:9"><span class="gsc_g_al">983</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:50px;height:110px;z-index:8"><span class="gsc_g_al">968</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:24px;height:136px;z-index:7"><span class="gsc_g_al">1192</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:12px;height:148px;z-index:6"><span class="gsc_g_al">1302</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:24px;height:136px;z-index:5"><span class="gsc_g_al">1194</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:29px;height:131px;z-index:4"><span class="gsc_g_al">1152</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:25px;height:135px;z-index:3"><span class="gsc_g_al">1182</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:4px;height:156px;z-index:2"><span class="gsc_g_al">1369</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:27px;height:133px;z-index:1"><span class="gsc_g_al">1168</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=beoArAkAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dbeoArAkAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>49 articles</span></div><div class="gsc_rsb_m_na"><div>2 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:4%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Mary Frances McMullin" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Mary Frances McMullin</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=2175268696339219833" class="gsc_prf_ila">Queens university Belfast</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at qub.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUHvTYLMESFMlxSXEBkVPiq4VwPGQtG9"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=beoArAkAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at"><i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis</a><div class="gs_gray">LM Scott, W Tong, RL Levine, MA Scott, PA Beer, MR Stratton, PA Futreal, ...</div><div class="gs_gray">New England Journal of Medicine 356 (5), 459-468<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17783766249591274929" class="gsc_a_ac gs_ibl">1483</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet</a><div class="gs_gray">T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ...</div><div class="gs_gray">Journal of Clinical Oncology 29 (6), 761<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8811835630546506063" class="gsc_a_ac gs_ibl">855</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not&nbsp;…</a><div class="gs_gray">AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, RK Hills, ...</div><div class="gs_gray">Cancer: Interdisciplinary International Journal of the American Cancer&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6591475663586040290" class="gsc_a_ac gs_ibl">633</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis</a><div class="gs_gray">MF McMullin, D Bareford, P Campbell, AR Green, C Harrison, B Hunt, ...</div><div class="gs_gray">British journal of haematology 130 (2), 174-195<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15150139275840563591" class="gsc_a_ac gs_ibl">416</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:738O_yMBCRsC" class="gsc_a_at">A Gain-of-Function Mutation in the <i>HIF2A</i> Gene in Familial Erythrocytosis</a><div class="gs_gray">MJ Percy, PW Furlow, GS Lucas, X Li, TRJ Lappin, MF McMullin, FS Lee</div><div class="gs_gray">New England Journal of Medicine 358 (2), 162-168<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4809555885392877897" class="gsc_a_ac gs_ibl">359</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial</a><div class="gs_gray">AK Burnett, NH Russell, RK Hills, D Bowen, J Kell, S Knapper, YG Morgan, ...</div><div class="gs_gray">The lancet oncology 16 (13), 1295-1305<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15094262339141858672" class="gsc_a_ac gs_ibl">356</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis</a><div class="gs_gray">MJ Percy, Q Zhao, A Flores, C Harrison, TRJ Lappin, PH Maxwell, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 103 (3), 654-659<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13418325394713737370" class="gsc_a_ac gs_ibl">349</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Guideline for investigation and management of adults and children presenting with a thrombocytosis</a><div class="gs_gray">CN Harrison, D Bareford, N Butt, P Campbell, E Conneally, M Drummond, ...</div><div class="gs_gray">British journal of haematology 149 (3), 352-375<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7995395734228716314" class="gsc_a_ac gs_ibl">298</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Factors influencing success of clinical genome sequencing across a broad spectrum of disorders</a><div class="gs_gray">JC Taylor, HC Martin, S Lise, J Broxholme, JB Cazier, A Rimmer, ...</div><div class="gs_gray">Nature genetics 47 (7), 717-726<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4149896841054535215" class="gsc_a_ac gs_ibl">289</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Classification and personalized prognosis in myeloproliferative neoplasms</a><div class="gs_gray">J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ...</div><div class="gs_gray">New England Journal of Medicine 379 (15), 1416-1430<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15070769045805736821" class="gsc_a_ac gs_ibl">286</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Two routes to leukemic transformation after a <i>JAK2</i> mutation–positive myeloproliferative neoplasm</a><div class="gs_gray">PA Beer, F Delhommeau, JP LeCouédic, MA Dawson, E Chen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (14), 2891-2900<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13328244996995402799" class="gsc_a_ac gs_ibl">282</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference</a><div class="gs_gray">G Barosi, G Birgegard, G Finazzi, M Griesshammer, C Harrison, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 113 (20), 4829-4833<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13286260377005174874" class="gsc_a_ac gs_ibl">260</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Molecular and clinical features of the myeloproliferative neoplasm associated with <i>JAK2</i> exon 12 mutations</a><div class="gs_gray">F Passamonti, C Elena, S Schnittger, RC Skoda, AR Green, F Girodon, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 117 (10), 2813-2816<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4161100370527565512" class="gsc_a_ac gs_ibl">257</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial</a><div class="gs_gray">AK Burnett, RK Hills, DW Milligan, AH Goldstone, AG Prentice, ...</div><div class="gs_gray">J Clin Oncol 28 (4), 586-595<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7269378360551970602" class="gsc_a_ac gs_ibl">233</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">A randomized comparison of daunorubicin 90 mg/m<sup>2</sup> vs 60 mg/m<sup>2</sup> in AML induction: results from the UK NCRI AML17 trial in 1206 patients</a><div class="gs_gray">AK Burnett, NH Russell, RK Hills, J Kell, J Cavenagh, L Kjeldsen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 125 (25), 3878-3885<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11657753032614609629" class="gsc_a_ac gs_ibl">226</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project</a><div class="gs_gray">G Barosi, R Mesa, G Finazzi, C Harrison, JJ Kiladjian, E Lengfelder, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (23), 4778-4781<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4608013556621745351" class="gsc_a_ac gs_ibl">223</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Mutation of von Hippel–Lindau tumour suppressor and human cardiopulmonary physiology</a><div class="gs_gray">TG Smith, JT Brooks, GM Balanos, TR Lappin, DM Layton, DL Leedham, ...</div><div class="gs_gray">PLoS medicine 3 (7), e290<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1622264964769686195" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy</a><div class="gs_gray">AK Burnett, NH Russell, J Kell, M Dennis, D Milligan, S Paolini, J Yin, ...</div><div class="gs_gray">Journal of clinical oncology 28 (14), 2389-2395<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10569083404349537873" class="gsc_a_ac gs_ibl">175</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove</a><div class="gs_gray">MJ Percy, PW Furlow, PA Beer, TRJ Lappin, MF McMullin, FS Lee</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (6), 2193-2196<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8732911650046191476" class="gsc_a_ac gs_ibl">172</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;citation_for_view=beoArAkAAAAJ:FAceZFleit8C" class="gsc_a_at">Regulation of human metabolism by hypoxia-inducible factor</a><div class="gs_gray">F Formenti, D Constantin-Teodosiu, Y Emmanuel, J Cheeseman, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 107 (28), 12722-12727<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10082409644434142885" class="gsc_a_ac gs_ibl">169</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">How common are myeloproliferative neoplasms? A systematic review and meta‐analysis</a><div class="gs_gray">GJ Titmarsh, AS Duncombe, MF McMullin, M O'Rorke, R Mesa, ...</div><div class="gs_gray">American Journal of Hematology 89 (6), 581-587<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9146566787249134130" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:MLfJN-KU85MC" class="gsc_a_at">The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia&nbsp;…</a><div class="gs_gray">AK Burnett, RK Hills, AE Hunter, D Milligan, WJ Kell, K Wheatley, J Yin, ...</div><div class="gs_gray">Leukemia 27 (1), 75-81<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8570555785265605103" class="gsc_a_ac gs_ibl">159</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:FiytvqdAVhgC" class="gsc_a_at">The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3</a><div class="gs_gray">MB Hookham, J Elliott, Y Suessmuth, J Staerk, AC Ward, W Vainchenker, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 109 (11), 4924-4929<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14485405740722141084" class="gsc_a_ac gs_ibl">158</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial</a><div class="gs_gray">AK Burnett, D Milligan, A Goldstone, A Prentice, MF McMullin, M Dennis, ...</div><div class="gs_gray">British journal of haematology 145 (3), 318-332<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2322486194344680472" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:43bX7VzcjpAC" class="gsc_a_at">The classification and diagnosis of erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">International journal of laboratory hematology 30 (6), 447-459<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13787757434491423073" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival</a><div class="gs_gray">AK Burnett, NH Russell, AE Hunter, D Milligan, S Knapper, K Wheatley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (8), 1384-1394<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6638879472370811478" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Novel exon 12 mutations in the <i>HIF2A</i> gene associated with erythrocytosis</a><div class="gs_gray">MJ Percy, PA Beer, G Campbell, AW Dekker, AR Green, D Oscier, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (11), 5400-5402<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13710733187845390021" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.</a><div class="gs_gray">MF McMullin, JT Reilly, P Campbell, D Bareford, AR Green, CN Harrison, ...</div><div class="gs_gray">British journal of haematology 138 (6), 821-822<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5868510658481870531" class="gsc_a_ac gs_ibl">125</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:LI9QrySNdTsC" class="gsc_a_at">European LeukemiaNet. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet</a><div class="gs_gray">T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ...</div><div class="gs_gray">J Clin Oncol 29 (6), 761-770<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8689440210369440175" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Chronic myeloid leukaemia in the 21st century</a><div class="gs_gray">R Frazer, AE Irvine, MF McMullin</div><div class="gs_gray">The Ulster medical journal 76 (1), 8<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12875319836370100098" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Genetic basis of congenital erythrocytosis: mutation update and online databases</a><div class="gs_gray">C Bento, MJ Percy, B Gardie, TM Maia, R van Wijk, S Perrotta, ...</div><div class="gs_gray">Human mutation 35 (1), 15-26<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14137179739802184964" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry</a><div class="gs_gray">MJ Percy, MF McMullin, SN Jowitt, M Potter, M Treacy, WH Watson, ...</div><div class="gs_gray">Blood 102 (3), 1097-1099<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11898027440002188160" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Guideline for the diagnosis and management of myelofibrosis</a><div class="gs_gray">JT Reilly, MF McMullin, PA Beer, N Butt, E Conneally, A Duncombe, ...</div><div class="gs_gray">British journal of haematology 158 (4), 453-471<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12771760488355227064" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation</a><div class="gs_gray">A Alvarez-Larrán, A Pereira, P Guglielmelli, JC Hernández-Boluda, ...</div><div class="gs_gray">haematologica 101 (8), 926<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9689672983259724964" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:W5xh706n7nkC" class="gsc_a_at">The <i>JAK2</i> 46/1 haplotype predisposes to <i>MPL</i>-mutated myeloproliferative neoplasms</a><div class="gs_gray">AV Jones, PJ Campbell, PA Beer, S Schnittger, AM Vannucchi, K Zoi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (22), 4517-4523<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6827939682341936559" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:r_AWSJRzSzQC" class="gsc_a_at"><i>JAK2V617F</i> homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone</a><div class="gs_gray">AL Godfrey, E Chen, F Pagano, CA Ortmann, Y Silber, B Bellosillo, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (13), 2704-2707<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12069914286349616153" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of <i>JAK2 </i>V617F and other relevant mutations</a><div class="gs_gray">AJ Bench, HE White, L Foroni, AL Godfrey, G Gerrard, S Akiki, A Awan, ...</div><div class="gs_gray">British journal of haematology 160 (1), 25-34<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3184812862272367388" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide</a><div class="gs_gray">CN Harrison, AJ Mead, A Panchal, S Fox, C Yap, E Gbandi, A Houlton, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (17), 1889-1897<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17459845307272654386" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:HIFyuExEbWQC" class="gsc_a_at">The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels</a><div class="gs_gray">MJ Percy, LM Scott, WN Erber, CN Harrison, JT Reilly, FGC Jones, ...</div><div class="gs_gray">haematologica 92 (12), 1607-1614<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11194666681052518686" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative&nbsp;…</a><div class="gs_gray">JV Jovanovic, A Ivey, AM Vannucchi, E Lippert, EO Leibundgut, ...</div><div class="gs_gray">Leukemia 27 (10), 2032-2039<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10675869270607845710" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones</a><div class="gs_gray">PA Beer, AV Jones, AJ Bench, A Goday‐Fernandez, EM Boyd, ...</div><div class="gs_gray">British journal of haematology 144 (6), 904-908<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7515768606705251528" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation</a><div class="gs_gray">F Formenti, PA Beer, QPP Croft, KL Dorrington, DP Gale, TRJ Lappin, ...</div><div class="gs_gray">The FASEB Journal 25 (6), 2001-2011<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7358994075947808001" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">JAK2 V617F: a single mutation in the myeloproliferative group of disorders</a><div class="gs_gray">D McLornan, M Percy, MF McMullin</div><div class="gs_gray">The Ulster medical journal 75 (2), 112<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11081412621063027073" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:uWiczbcajpAC" class="gsc_a_at">The worldwide distribution of the <i>VHL 598C</i>&gt;<i>T</i> mutation indicates a single founding event</a><div class="gs_gray">E Liu, MJ Percy, CI Amos, Y Guan, S Shete, DW Stockton, MF McMullin, ...</div><div class="gs_gray">Blood 103 (5), 1937-1940<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7863928884566365791" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">The diagnosis and management of erythrocytosis</a><div class="gs_gray">C Keohane, MF McMullin, C Harrison</div><div class="gs_gray">Bmj 347<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13826266225060736788" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:r0BpntZqJG4C" class="gsc_a_at">High bax expression is a good prognostic indicator in acute myeloid leukaemia</a><div class="gs_gray">YL Ong, MF McMullin, KEM Bailie, TRJ Lappin, FGC Jones, AE Irvine</div><div class="gs_gray">British journal of haematology 111 (1), 182-189<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2471701689439625660" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria</a><div class="gs_gray">MF McMullin, P Hillmen, J Jackson, P Ganly, L Luzzatto</div><div class="gs_gray">Journal of internal medicine 235 (1), 85-89<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=200859303586645471" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial</a><div class="gs_gray">AK Burnett, RK Hills, D Grimwade, JV Jovanovic, J Craig, MF McMullin, ...</div><div class="gs_gray">Leukemia 27 (4), 843-851<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1332850280374889062" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Global down-regulation of <i>HOX</i> gene expression in PML-RARα<sup>+</sup> acute promyelocytic leukemia identified by small-array real-time PCR</a><div class="gs_gray">A Thompson, MF Quinn, D Grimwade, CM O'Neill, MR Ahmed, S Grimes, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 101 (4), 1558-1565<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5996342219685448072" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Molecular diagnostics of myeloproliferative neoplasms</a><div class="gs_gray">SE Langabeer, H Andrikovics, J Asp, B Bellosillo, S Carillo, K Haslam, ...</div><div class="gs_gray">European journal of haematology 95 (4), 270-279<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6224611694723938348" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1α (HIF-1α) does not impair Pro-564 hydroxylation</a><div class="gs_gray">MJ Percy, SM Mooney, MF McMullin, A Flores, TRJ Lappin, FS Lee</div><div class="gs_gray">Molecular cancer 2 (1), 1-7<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17217874944807248524" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study&nbsp;…</a><div class="gs_gray">JC Marsh, RM Pearce, MBC Koh, Z Lim, A Pagliuca, GJ Mufti, J Perry, ...</div><div class="gs_gray">Bone marrow transplantation 49 (1), 42-48<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10724695112631765047" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Long term management of patients after splenectomy.</a><div class="gs_gray">M McMullin, G Johnston</div><div class="gs_gray">BMJ: British Medical Journal 307 (6916), 1372<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16583367539946428124" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:PyEswDtIyv0C" class="gsc_a_at">A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia</a><div class="gs_gray">CL Andersen, MF McMullin, E Ejerblad, S Zweegman, C Harrison, ...</div><div class="gs_gray">British journal of haematology 162 (4), 498-508<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16686438466294479098" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Haemoglobin during pregnancy: relationship to erythropoietin and haematinic status</a><div class="gs_gray">MF McMullin, R White, T Lappin, J Reeves, G MacKenzie</div><div class="gs_gray">European journal of haematology 71 (1), 44-50<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5553520420141602678" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Erythrocytosis due to a mutation in the erythropoietin receptor gene</a><div class="gs_gray">MJ Percy, MF McMullin, AWW Roques, NB Westwood, J Acharya, ...</div><div class="gs_gray">British journal of haematology 100 (2), 407-410<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9976158565880073627" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Erythrocytosis-associated HIF-2α mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline</a><div class="gs_gray">PW Furlow, MJ Percy, S Sutherland, C Bierl, MF McMullin, SR Master, ...</div><div class="gs_gray">Journal of Biological Chemistry 284 (14), 9050-9058<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=588463496498406415" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:U_HPUtbDl20C" class="gsc_a_at">A guideline for the diagnosis and management of polycythaemia vera</a><div class="gs_gray">MF McMullin, CN Harrison, S Ali, C Cargo, F Chen, J Ewing, M Garg, ...</div><div class="gs_gray">British journal of haematology 184 (2), 176-191<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3042510572519106063" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Idiopathic erythrocytosis: a disappearing entity</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">ASH Education Program Book 2009 (1), 629-635<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13764245041640069712" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:UuEBAcK4md4C" class="gsc_a_at">UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all&nbsp;…</a><div class="gs_gray">AK Burnett, NH Russell, RK Hills, D Bowen, J Kell, S Knapper, YG Morgan, ...</div><div class="gs_gray">Lancet Oncol 16 (13), 1295-1305<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12587649159717494985" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase</a><div class="gs_gray">MJ Percy, MJS Gillespie, G Savage, AE Hughes, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (10), 3447-3449<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5606971930226594724" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization</a><div class="gs_gray">NB Westwood, AM Gruszka‐Westwood, CE Pearson, CFM DeLord, ...</div><div class="gs_gray">British journal of haematology 110 (4), 839-846<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1796584087859338864" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Homocysteine and methylmalonic acid as indicators of folate and vitamin B<sub>12</sub> deficiency in pregnancy</a><div class="gs_gray">MF McMullin, PB Young, KEM Bailie, GA Savage, TRJ Lappin, R White</div><div class="gs_gray">Clinical &amp; Laboratory Haematology 23 (3), 161-165<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13684031907617557937,1969387397397419686" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations</a><div class="gs_gray">C Camps, N Petousi, C Bento, H Cario, RR Copley, MF McMullin, ...</div><div class="gs_gray">haematologica 101 (11), 1306<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16214614681970933294" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence</a><div class="gs_gray">A Tefferi, HK Al-Ali, G Barosi, T Devos, H Gisslinger, Q Jiang, JJ Kiladjian, ...</div><div class="gs_gray">Leukemia 31 (4), 896-902<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2571874085357841601" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:WF5omc3nYNoC" class="gsc_a_at">The molecular basis of disorders of red cell enzymes.</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Journal of clinical pathology 52 (4), 241<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=646517017081465461" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia</a><div class="gs_gray">M Dennis, N Russell, RK Hills, C Hemmaway, N Panoskaltsis, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 125 (19), 2923-2932<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13465671116542857512" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:8d8msizDQcsC" class="gsc_a_at">Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis</a><div class="gs_gray">MJ Percy, NN Butt, GM Crotty, MW Drummond, C Harrison, GL Jones, ...</div><div class="gs_gray">haematologica 94 (9), 1321<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10161018805561852765" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:mB3voiENLucC" class="gsc_a_at">Outcome of azacitidine therapy in acute myeloid leukemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature</a><div class="gs_gray">CF Craddock, AE Houlton, LS Quek, P Ferguson, E Gbandi, C Roberts, ...</div><div class="gs_gray">Clinical Cancer Research 23 (21), 6430-6440<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2003139058193231074" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:D_sINldO8mEC" class="gsc_a_at">Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease</a><div class="gs_gray">AR Muir, MF McMullin, C Patterson, PP McKeown</div><div class="gs_gray">Heart 95 (15), 1225-1229<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5392413111727496357" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">The V617F JAK2 mutation and the myeloproliferative disorders</a><div class="gs_gray">MJ Percy, MF McMullin</div><div class="gs_gray">Hematological oncology 23 (3‐4), 91-93<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14459245369738539786" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations</a><div class="gs_gray">M Marchetti, G Barosi, F Cervantes, G Birgegård, M Griesshammer, ...</div><div class="gs_gray">Leukemia 31 (4), 882-888<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12299985001801261171" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Two new mutations in the <i>HIF2A</i> gene associated with erythrocytosis</a><div class="gs_gray">MJ Percy, YJ Chung, C Harrison, J Mercieca, AV Hoffbrand, CL Dinardo, ...</div><div class="gs_gray">American journal of hematology 87 (4), 439-442<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7768160087234649137" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms</a><div class="gs_gray">LA Anderson, AS Duncombe, M Hughes, ME Mills, JC Wilson, ...</div><div class="gs_gray">American journal of hematology 87 (2), 175-182<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4015975587423667106" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms</a><div class="gs_gray">G Greenfield, S McPherson, K Mills, MF McMullin</div><div class="gs_gray">Journal of translational medicine 16 (1), 1-16<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15475492713799673198" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions</a><div class="gs_gray">A Aziz, EJ Baxter, C Edwards, CY Cheong, M Ito, A Bench, R Kelley, ...</div><div class="gs_gray">The Journal of clinical investigation 123 (5), 2169-2182<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16093381791288931846" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:35r97b3x0nAC" class="gsc_a_at">A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British Society for Haematology Guideline</a><div class="gs_gray">MFF McMullin, AJ Mead, S Ali, C Cargo, F Chen, J Ewing, M Garg, ...</div><div class="gs_gray">British journal of haematology 184 (2), 161<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7177190279677534879" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:p__nRnzSRKYC" class="gsc_a_at">HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy</a><div class="gs_gray">GJ Dickson, FG Liberante, LM Kettyle, KA O’Hagan, DPJ Finnegan, ...</div><div class="gs_gray">Haematologica 98 (8), 1216<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8078159642734200832" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia</a><div class="gs_gray">CN Harrison, N Butt, P Campbell, E Conneally, M Drummond, AR Green, ...</div><div class="gs_gray">British journal of haematology 167 (3), 421-423<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11917731138622654925" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera</a><div class="gs_gray">H Cario, K Schwarz, JM Herter, V Komrska, MF McMullin, M Minkov, ...</div><div class="gs_gray">British journal of haematology 142 (4), 622-626<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=310774646646824994" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Low-dose thalidomide in myelofibrosis</a><div class="gs_gray">R Weinkove, JT Reilly, MF McMullin, NJ Curtin, D Radia, CN Harrison</div><div class="gs_gray">Haematologica 93 (7), 1100-1101<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2238369152298850097" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Community-acquired infections and their association with myeloid malignancies</a><div class="gs_gray">GJ Titmarsh, MF McMullin, CM McShane, M Clarke, EA Engels, ...</div><div class="gs_gray">Cancer epidemiology 38 (1), 56-61<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=771841562929624694" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Clinical and hematological presentation of children and adolescents with polycythemia vera</a><div class="gs_gray">H Cario, MF McMullin, HL Pahl</div><div class="gs_gray">Annals of hematology 88 (8), 713-719<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8364385398681383224" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Results of the myeloproliferative neoplasms-research consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) therapy for the&nbsp;…</a><div class="gs_gray">J Mascarenhas, HE Kosiorek, JT Prchal, A Rambaldi, D Berenzon, ...</div><div class="gs_gray">Blood 132, 577<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8335914425748202320" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:geHnlv5EZngC" class="gsc_a_at">Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of&nbsp;…</a><div class="gs_gray">JT Reilly, MF McMullin, PA Beer, N Butt, E Conneally, AS Duncombe, ...</div><div class="gs_gray">British journal of haematology 167 (3), 418-420<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5132345113664053619" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Prognostic and therapeutic relevance of c‐FLIP in acute myeloid leukaemia</a><div class="gs_gray">D McLornan, J Hay, K McLaughlin, C Holohan, AK Burnett, RK Hills, ...</div><div class="gs_gray">British journal of haematology 160 (2), 188-198<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13076159561636881963" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Assessment of <i>CALR</i> mutations in myelofibrosis patients, post‐allogeneic stem cell transplantation</a><div class="gs_gray">K Haslam, SE Langabeer, K Molloy, MF McMullin, E Conneally</div><div class="gs_gray">British journal of haematology 166 (5), 800-802<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8494533566676024629" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Phase 3 study of pomalidomide in myeloproliferative neoplasm (MPN)-associated myelofibrosis with RBC-transfusion-dependence</a><div class="gs_gray">A Tefferi, F Passamonti, T Barbui, G Barosi, K Begna, M Cazzola, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 394-394<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12604489758644493800" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:4vMrXwiscB8C" class="gsc_a_at">The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome</a><div class="gs_gray">AK Burnett, RK Hills, A Hunter, D Milligan, J Kell, K Wheatley, J Yin, ...</div><div class="gs_gray">Leukemia 25 (7), 1122-1127<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11240089909632831470" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">The molecular basis of disorders of the red cell membrane.</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Journal of clinical pathology 52 (4), 245<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12114525873535211607" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Late onset immune pancytopenia following bone marrow transplantation</a><div class="gs_gray">A Bashey, I Owen, GF Lucas, NW Amphlett, MM Jones, A Lawal, ...</div><div class="gs_gray">British journal of haematology 78 (2), 268-274<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=914019042980414888" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Management of polycythaemia vera: a critical review of current data</a><div class="gs_gray">MF McMullin, BS Wilkins, CN Harrison</div><div class="gs_gray">British journal of haematology 172 (3), 337-349<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14584364450204763482" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">A new polycythaemia vera‐associated SOCS3 SH2 mutant (SOCS3<sup>F136L</sup>) cannot regulate erythropoietin responses</a><div class="gs_gray">Y Suessmuth, J Elliott, MJ Percy, M Inami, H Attal, CN Harrison, ...</div><div class="gs_gray">British journal of haematology 147 (4), 450-458<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6313630102925541146" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Comparison of the mouse spleen cell assay and a radioimmunoassay for the measurement of serum erythropoietin</a><div class="gs_gray">TRJ Lappin, GE Elder, T Taylor, MF McMullin, JM Bridges</div><div class="gs_gray">British journal of haematology 70 (1), 117-120<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1204575046642765921" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of&nbsp;…</a><div class="gs_gray">MF McMullin, CN Harrison, D Niederwieser, H Demuynck, N Jäkel, ...</div><div class="gs_gray">Experimental hematology &amp; oncology 4 (1), 1-6<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17123964481961947819" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">HIF pathway mutations and erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Expert review of hematology 3 (1), 93-101<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6347442858416105066" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">LNK mutations and myeloproliferative disorders</a><div class="gs_gray">MF McMullin, H Cario</div><div class="gs_gray">American journal of hematology 91 (2), 248-251<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8885701241482707082" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Erythrocytosis in children and adolescents—classification, characterization, and consensus recommendations for the diagnostic approach</a><div class="gs_gray">H Cario, M Frances McMullin, C Bento, D Pospisilova, MJ Percy, ...</div><div class="gs_gray">Pediatric blood &amp; cancer 60 (11), 1734-1738<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14653014695623802916" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Anthracycline cardiotoxicity</a><div class="gs_gray">PG Horan, MF McMullin, PP McKeown</div><div class="gs_gray">European heart journal 27 (10), 1137-1138<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13292631106292963667" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=beoArAkAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">J anus kinase Inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?</a><div class="gs_gray">C Harrison, S Verstovsek, MF McMullin, R Mesa</div><div class="gs_gray">British journal of haematology 157 (4), 426-437<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1550126513983388377" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4DMP91E08xMC" class="gsc_a_at">The role of PHD2 mutations in the pathogenesis of erythrocytosis</a><div class="gs_gray">B Gardie, MJ Percy, D Hoogewijs, R Chowdhury, C Bento, PR Arsenault, ...</div><div class="gs_gray">Hypoxia 2, 71<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1508558596786887344" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Treatment target in polycythemia vera.</a><div class="gs_gray">R Marchioli, AM Vannucchi, T Barbui</div><div class="gs_gray">The New England journal of medicine 368 (16), 1556-1556<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5227288769588745536" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis</a><div class="gs_gray">MJ Percy, FG Jones, AR Green, JT Reilly, MF McMullin</div><div class="gs_gray">Haematologica 91 (3), 413-414<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5535189323676665727" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls</a><div class="gs_gray">LA Anderson, G James, AS Duncombe, R Mesa, R Scherber, AC Dueck, ...</div><div class="gs_gray">American journal of hematology 90 (10), 864-870<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4474541882117660900" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study</a><div class="gs_gray">T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">Leukemia 33 (8), 1996-2005<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1958023886604038112" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Epidemiology of MPN: what do we know?</a><div class="gs_gray">LA Anderson, MF McMullin</div><div class="gs_gray">Current hematologic malignancy reports 9 (4), 340-349<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17130707101645501639" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Hydroxycarbamide plus aspirin versus aspirin alone in patients with essential thrombocythemia age 40 to 59 years without high-risk features</a><div class="gs_gray">AL Godfrey, PJ Campbell, C MacLean, G Buck, J Cook, J Temple, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (34), 3361<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8533597640458473517" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Epigenetics in myeloproliferative neoplasms</a><div class="gs_gray">S McPherson, MF McMullin, K Mills</div><div class="gs_gray">Journal of cellular and molecular medicine 21 (9), 1660-1667<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4980653085453913755" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Investigation and management of erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Current hematologic malignancy reports 11 (5), 342-347<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15704250298464877077" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Diagnosis and management of congenital and idiopathic erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Therapeutic advances in hematology 3 (6), 391-398<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3355172108442147963" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis</a><div class="gs_gray">MF McMullin, C Wu, MJ Percy, W Tong</div><div class="gs_gray">American journal of hematology 86 (11), 962<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3698885914775322063" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH‐binding lobe of cytochrome <i>b</i><sub>5</sub> reductase</a><div class="gs_gray">MJ Percy, LJ Crowley, CA Davis, MF McMullin, G Savage, J Hughes, ...</div><div class="gs_gray">British journal of haematology 129 (6), 847-853<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16971090621430509514" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Interim analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 global phase III trial of front line pegylated interferon alpha-2a vs. hydroxyurea in high&nbsp;…</a><div class="gs_gray">JO Mascarenhas, JT Prchal, A Rambaldi, RA Mesa, D Berenzon, ...</div><div class="gs_gray">Blood 128 (22), 479<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5077914059419748997" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.</a><div class="gs_gray">AE Irvine, MK Magill, LE Somerville, MF McMullin</div><div class="gs_gray">Experimental hematology 26 (5), 435-439<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8962438229886942810" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tuHXwOkdijsC" class="gsc_a_at">SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases</a><div class="gs_gray">J Elliott, Y Suessmuth, LM Scott, K Nahlik, MF McMullin, ...</div><div class="gs_gray">haematologica 94 (4), 576<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8552537444113363689" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:u9iWguZQMMsC" class="gsc_a_at">The therapeutic potential of the proteasome in leukaemia</a><div class="gs_gray">SM McCloskey, MF McMullin, B Walker, AE Irvine</div><div class="gs_gray">Hematological oncology 26 (2), 73-81<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4651356348677894581" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Molecular mechanisms of drug resistance in acute myeloid leukaemia</a><div class="gs_gray">DP McLornan, MF McMullin, P Johnston, DB Longley</div><div class="gs_gray">Expert opinion on drug metabolism &amp; toxicology 3 (3), 363-377<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17843919928969642868" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Sequence analysis of the 3′ hypoxia-responsive element of the human erythropoietin gene in patients with erythrocytosis</a><div class="gs_gray">MJ Percy, MF McMullin, TRJ Lappin</div><div class="gs_gray">Biochemical and molecular medicine 62 (1), 132-134<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3047201259633514169" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:olpn-zPbct0C" class="gsc_a_at">Serum erythropoietin levels in paroxysmal nocturnal haemoglobinuria: implications for therapy</a><div class="gs_gray">MF McMullin, P Hillmen, GE Elder, TRJ Lappin, L Luzzatto</div><div class="gs_gray">British journal of haematology 92 (4), 815-817<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5932328819217525757" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Comparison of diagnostic criteria for polycythaemia vera</a><div class="gs_gray">RC Turkington, EC Arnold, MJ Percy, LA Ranaghan, RJG Cuthbert, ...</div><div class="gs_gray">Hematology 12 (2), 123-130<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=423353896092379005" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology</a><div class="gs_gray">TG Smith, JT Brooks, GM Balanos, TR Lappin, DM Layton, DL Leedham, ...</div><div class="gs_gray">Integration in Respiratory Control, 51-56<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15714761009723642971" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Erythropoietin receptor and hematological disease</a><div class="gs_gray">MF McMullin, MJ Percy</div><div class="gs_gray">American journal of hematology 60 (1), 55-60<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10883955660919604846" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash</a><div class="gs_gray">MF McMullin, MB Finch</div><div class="gs_gray">Clinical rheumatology 14 (2), 204-207<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2490036085174894657" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5ugPr518TE4C" class="gsc_a_at">Low Dose Ara-C Versus Hydroxyurea with or without Retinoid in Older Patients Not Considered Fit for Intensive Chemotherapy: The UK NCRI AML14 Trial.</a><div class="gs_gray">AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 872-872<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5839641458661378549" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA)</a><div class="gs_gray">BP McILHATTON, C Keating, MD Curran, MF McMULLIN, JG Barr, ...</div><div class="gs_gray">Journal of medical microbiology 51 (6), 468-478<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=907781649822368420" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Proteasome proteolytic profile is linked to Bcr-Abl expression</a><div class="gs_gray">LJ Crawford, P Windrum, L Magill, JV Melo, L McCallum, MF McMullin, ...</div><div class="gs_gray">Experimental hematology 37 (3), 357-366<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1968707059982363910" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Red Cell Disorders</a><div class="gs_gray">JW Hamilton, FGC Jones, MF McMullin</div><div class="gs_gray">Hematology 9 (4), 307-309<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2781569498498650924" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:TQgYirikUcIC" class="gsc_a_at">Chromosomal abnormalities in Ph<sup>-</sup> cells of patients on imatinib</a><div class="gs_gray">MF McMullin, M Humphreys, J Byrne, NH Russell, RJ Cuthbert, ...</div><div class="gs_gray">Blood 102 (7), 2700-2701<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2201336860209934611" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:jgBuDB5drN8C" class="gsc_a_at">The Calreticulin gene and myeloproliferative neoplasms</a><div class="gs_gray">A Clinton, MF McMullin</div><div class="gs_gray">Journal of clinical pathology 69 (10), 841-845<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13758022188572575546" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Erythrocytosis associated with a novel missense mutation in the BPGM gene</a><div class="gs_gray">N Petousi, RR Copley, TRJ Lappin, SE Haggan, CM Bento, H Cario, ...</div><div class="gs_gray">Haematologica 99 (10), e201<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15185867588630629550" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Novel and Mediterranean β thalassemia mutations in the indigenous Northern Ireland population</a><div class="gs_gray">M Knott, KMA Ramadan, G Savage, FGC Jones, M El-Agnaf, MF McMullin, ...</div><div class="gs_gray">Blood Cells, Molecules, and Diseases 36 (2), 265-268<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8262111385573185429" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Ehil0879vHcC" class="gsc_a_at">Acute myeloid leukemia with concurrent myeloid sarcoma treated with autologous bone marrow transplantation: two illustrative cases and a literature review</a><div class="gs_gray">DPJ Finnegan, FGC Jones, MF McMullin</div><div class="gs_gray">Hematological oncology 23 (3‐4), 133-135<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12214839420991932396" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Polycythaemia‐inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor–EPOR chimeras</a><div class="gs_gray">M Gross, N Ben‐Califa, MF McMullin, MJ Percy, C Bento, H Cario, ...</div><div class="gs_gray">British journal of haematology 165 (4), 519-528<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3965178755032033265" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Expand: a Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis and Baseline Platelet Counts Between 50 × 10<sup>9</sup>/L and 99 × 10<sup>9</sup>/L</a><div class="gs_gray">CN Harrison, H Gisslinger, CB Miller, JJ Kiladjian, E Atienza, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 177-177<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9020984771889734842" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:jFemdcug13IC" class="gsc_a_at">Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in&nbsp;…</a><div class="gs_gray">P McGrattan, S Campbell, R Cuthbert, FGC Jones, MF McMullin, ...</div><div class="gs_gray">Journal of clinical pathology 61 (8), 903-908<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16090969024663796172" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Acute intestinal obstruction due to intramural haemorrhage in small intestine in a patient with severe haemophilia A and inhibitor</a><div class="gs_gray">KMA Ramadan, JP Lowry, A Wilkinson, O McNulty, MF McMullin, ...</div><div class="gs_gray">European journal of haematology 75 (2), 164-166<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6008375088003359318" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study</a><div class="gs_gray">A Rambaldi, A Iurlo, AM Vannucchi, R Noble, N von Bubnoff, A Guarini, ...</div><div class="gs_gray">Leukemia 34 (8), 2234-2237<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7051206759640616117" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:eflP2zaiRacC" class="gsc_a_at">Thrombotic thrombocytopenic purpura secondary to Streptococcus</a><div class="gs_gray">MJ Morrin, FGC Jones, J McConville, C Arnold, B Mullan, GG Lavery, ...</div><div class="gs_gray">Transfusion and apheresis science 34 (2), 153-155<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5444194370986675654" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Bcl-2 family members as prognostic indicators in AML</a><div class="gs_gray">AE Irvine, MF McMullin, YL Ong</div><div class="gs_gray">Hematology 7 (1), 21-31<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9881747108633606589" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Congenital erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">International journal of laboratory hematology 38, 59-65<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3649650571635987485" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Nilotinib 300 mg BID as frontline treatment of CML: prospective analysis of the Xpert BCR-ABL monitor system and significance of 3-month molecular response</a><div class="gs_gray">ME O’Dwyer, R Swords, A Nagler, MF McMullin, PD le Coutre, ...</div><div class="gs_gray">Leukemia research 38 (3), 310-315<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4580271597304354205" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">A randomised comparison of clofarabine versus low dose Ara-C as first line treatment for older patients with AML</a><div class="gs_gray">AK Burnett, NH Russell, MF McMullin, J Kell, S Ali, P Moreton, AH Wei, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 889-889<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3133830214811429799" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Clinical utility gene card for: familial erythrocytosis</a><div class="gs_gray">K Hussein, M Percy, MF McMullin</div><div class="gs_gray">European Journal of Human Genetics 20 (5), 4-4<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=340626156809453998" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:1taIhTC69MYC" class="gsc_a_at">Nilotinib 300 Mg Twice Daily Is Effective and Well Tolerated as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia in Chronic Phase: Preliminary Results of the ICORG&nbsp;…</a><div class="gs_gray">MC O'Dwyer, E Kent, M Parker, RT Swords, F Giles, P le Coutre, ...</div><div class="gs_gray">Blood 114 (22), 3294<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14492959887560859302" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">A review of the therapeutic agents used in the management of polycythaemia vera</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Hematological oncology 25 (2), 58-65<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5029293325195159529" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Second cancers in MPN: Survival analysis from an international study</a><div class="gs_gray">M Marchetti, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">American journal of hematology 95 (3), 295-301<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1058347833845508346" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Primary familial and congenital polycythemia</a><div class="gs_gray">C Bento, MF McMullin, M Percy, H Cario</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13576760836206840123" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:w0F2JDEymm0C" class="gsc_a_at">The management of ‘low‐risk’and ‘intermediate‐risk’patients with primary thrombocythaemia</a><div class="gs_gray">TC Pearson, D Bareford, J Craig, EL Egan, AR Green, GS Lucas, ...</div><div class="gs_gray">British journal of haematology 106 (3), 833-834<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17246119410717210721" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Inaccurate haemoglobin estimation in Waldenstrom's macroglobulinaemia.</a><div class="gs_gray">MF McMullin, HJ Wilkin, E Elder</div><div class="gs_gray">Journal of Clinical Pathology 48 (8), 787<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14911502731768027038" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Serum erythropoietic activity in acute anemia—An animal model</a><div class="gs_gray">MF McMullin, TRJ Lappin, GE Elder, T Taylor, JM Bridges</div><div class="gs_gray">Biochemical medicine and metabolic biology 41 (1), 30-35<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12468631957432970656" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Protein deregulation associated with breast cancer metastasis</a><div class="gs_gray">KK Chan, KB Matchett, PM McEnhill, MF McMullin, Y El-Tanani, ...</div><div class="gs_gray">Cytokine &amp; growth factor reviews 26 (4), 415-423<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1378803079557910568" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post&nbsp;…</a><div class="gs_gray">MF McMullin, CN Harrison, D Niederwieser, H Demuynck, N Jakel, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2838-2838<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15238351877599992757" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WZBGuue-350C" class="gsc_a_at">Prolonged molecular remission in PML-RAR [alpha]-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone&nbsp;…</a><div class="gs_gray">MF McMullin, E Nugent, A Thompson, D Hull, FGC Jones, D Grimwade</div><div class="gs_gray">Leukemia 19 (9), 1676-1676<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8795494304997057842" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:OTTXONDVkokC" class="gsc_a_at">Reasons for survival improvement in core binding factor AML: a 25 year analysis of the UK MRC/NCRI AML trials</a><div class="gs_gray">AK Burnett, RK Hills, N Russell, D Milligan, AE Hunter, RE Clark, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 358-358<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11040276087073870951" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland</a><div class="gs_gray">PC Winter, MF McMullin, MA Catherwood</div><div class="gs_gray">Leukemia 22 (8), 1629-1631<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3759563678932948081" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:dshw04ExmUIC" class="gsc_a_at">Erythropoietic response to hypobaric hypoxia in rabbits.</a><div class="gs_gray">MF McMullin, TR Lappin, GE Elder, GA Savage, JM Bridges</div><div class="gs_gray">Biomedica biochimica acta 47 (6), 523-527<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4511398714415678029" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study</a><div class="gs_gray">V De Stefano, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 135 (5), 381-386<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1370077386363917195" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">An evaluation of 17 years of low dose cytarabine as therapy for AML patients not fit for intensive treatment, including patients with adverse cytogenetics, shows improving&nbsp;…</a><div class="gs_gray">M Dennis, RK Hills, NH Russell, M Copland, I Thomas, MFF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 3874&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16133816716552204640" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat</a><div class="gs_gray">CL Andersen, ME Bjørn, MF McMullin, C Harrison, J Samuelsson, ...</div><div class="gs_gray">Leukemia research 38 (7), 816-821<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17216893445602873178" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Handwritten undergraduate case reports</a><div class="gs_gray">K McGlade, C Cargo, D Fogarty, M Boohan, M McMullin</div><div class="gs_gray">The clinical teacher 9 (2), 112-118<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14897913431961601037" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients</a><div class="gs_gray">OM Sheehy, AE Irvine, RJG Cuthbert, MW Humphreys, MF McMullin</div><div class="gs_gray">Hematology 13 (3), 133-136<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9046336593202317463" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis</a><div class="gs_gray">MF McMullin, O Buckley, MK Magill, AE Irvine</div><div class="gs_gray">Leukemia research 22 (8), 735-740<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7785588174402958909" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Br1UauaknNIC" class="gsc_a_at">Congenital myelodysplasia: a newly described disease entity?</a><div class="gs_gray">M McMullin, M Chisholm, JM Hows</div><div class="gs_gray">British journal of haematology 79 (2), 340-342<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15199171838548391362" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Education research: flipped classroom in neurology: principles, practices, and perspectives</a><div class="gs_gray">S Sandrone, JV Berthaud, C Carlson, J Cios, N Dixit, A Farheen, J Kraker, ...</div><div class="gs_gray">Neurology 93 (1), e106-e111<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7389328547662666014,12219276670883621598" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia</a><div class="gs_gray">FG Liberante, T Pouryahya, MF McMullin, SD Zhang, KI Mills</div><div class="gs_gray">Oncotarget 7 (6), 6609<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3671611477918355668" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ufrVoPGSRksC" class="gsc_a_at">A Randomised Comparison of Daunorubicin 90mg/m<sup>2</sup> Vs 60mg/m<sup>2 </sup>in AML Induction: Results from the UK NCRI AML17 Trial in 1206 Patients</a><div class="gs_gray">AK Burnett, N Russell, RK Hills, J Kell, J Cavenagh, L Kjeldsen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 7-7<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=680766403235161501" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Mutational spectrum defines primary and secondary myelofibrosis</a><div class="gs_gray">KI Mills, MF McMullin</div><div class="gs_gray">haematologica 99 (1), 2<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9628617629226267419" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma</a><div class="gs_gray">D Ramanujam, F McNicholl, D Furby, D Richardson, RJG Cuthbert, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 50 (10), 1721-1722<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15449463847880671441" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Pyruvate kinase deficient hemolytic anemia in the Northern Irish population</a><div class="gs_gray">MJ Percy, R Van Wijk, S Haggan, GA Savage, K Boyd, S Dempsey, ...</div><div class="gs_gray">Blood Cells, Molecules, and Diseases 39 (2), 189-194<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16889887287433345199" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms</a><div class="gs_gray">AS Duncombe, LA Anderson, G James, F De Vocht, L Fritschi, R Mesa, ...</div><div class="gs_gray">HemaSphere 4 (1)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2930038792341239774" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib</a><div class="gs_gray">JM O’Sullivan, A Hamblin, C Yap, S Fox, R Boucher, A Panchal, S Alimam, ...</div><div class="gs_gray">Blood 134 (23), 2107-2111<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15625158299304028849" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:F1b5ZUV5XREC" class="gsc_a_at"><i>HFE</i> mutations in idiopathic erythrocytosis</a><div class="gs_gray">G Biagetti, M Catherwood, N Robson, I Bertozzi, E Cosi, MF McMullin, ...</div><div class="gs_gray">British journal of haematology 181 (2), 270-272<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12901541597155338833" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Secondary erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Hematology 19 (3), 183-184<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=313000457403504433" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Clinical utility gene card for: hereditary thrombocythemia</a><div class="gs_gray">K Hussein, M Percy, MF McMullin, J Schwarz, S Schnittger, N Porret, ...</div><div class="gs_gray">European journal of human genetics 22 (2), 293-293<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8255153111517936744" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Characteristics and outcomes of haematology patients admitted to the intensive care unit</a><div class="gs_gray">C McCaughey, B Blackwood, M Glackin, M Brady, MF McMullin</div><div class="gs_gray">Nursing in critical care 18 (4), 193-199<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4380390588702245795" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">The addition of gemtuzumab ozogamicin to low dose Ara-C improves remission rates but not survival: results of the UK LRF AML14 and NCRI AML16 “Pick a Winner” comparison</a><div class="gs_gray">A Burnett, R Hills, AE Hunter, D Milligan, WJ Kell, K Wheatley, J Yin, ...</div><div class="gs_gray">Blood 116 (21), 18<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13315435686772867598" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation</a><div class="gs_gray">A Hayat, SR McCann, S Langabeer, S Irvine, MF McMullin, E Conneally</div><div class="gs_gray">Haematologica 94 (2), 296<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14447379813503566758" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Antineutrophil cytoplasmic antibodies in myelodysplasia.</a><div class="gs_gray">DR Hull, SA McMillan, IM Rea, N Boyd, MF McMullin</div><div class="gs_gray">The Ulster medical journal 65 (1), 55<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7309202514549176214" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Impact on MPN symptoms and quality of life of front line pegylated interferon alpha-2a vs. hydroxyurea in high risk polycythemia vera and essential thrombocythemia: results of&nbsp;…</a><div class="gs_gray">RA Mesa, HE Kosiorek, J Mascarenhas, JT Prchal, A Rambaldi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 132 (Supplement 1&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3562160846268812938" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ubry08Y2EpUC" class="gsc_a_at">A long-term safety and efficacy study of givinostat in patients with polycythemia vera: the first 4 years of treatment</a><div class="gs_gray">G Finazzi, A Iurlo, B Martino, G Carli, A Guarini, R Noble, AM Vannucchi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 1648&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13742865041702110949" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Diagnostic pathway for the investigation of thrombocytosis</a><div class="gs_gray">CN Harrison, N Butt, P Campbell, E Conneally, M Drummond, AR Green, ...</div><div class="gs_gray">British journal of haematology 161 (4), 604-606<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11710303362943095722" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia In Chronic Phase: Updated Results of the ICORG 0802 Phase 2 Study with Analysis of&nbsp;…</a><div class="gs_gray">E Conneally, RT Swords, FJ Giles, MF McMullin, P le Coutre, ...</div><div class="gs_gray">Blood 116 (21), 3427<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5346694104017098113" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Genotyping of thiopurine methyltransferase in patients with acute leukemia using LightCycler PCR</a><div class="gs_gray">JEA Davison, MF McMullin, MA Catherwood</div><div class="gs_gray">Leukemia &amp; lymphoma 47 (8), 1624-1628<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16386180015256862002" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">The optimal management of polycythaemia vera</a><div class="gs_gray">MF McMullin, D Bareford, J Craig, AR Green, C Harrison, DG Oscier, ...</div><div class="gs_gray">British journal of haematology 120 (3), 543-544<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18320564040621517855" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Hereditary benign telangiectasia--first family in Northern Ireland.</a><div class="gs_gray">F McNicholl, MF McMullin, NC Nevin, C McMillan</div><div class="gs_gray">The Ulster medical journal 68 (2), 106<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5238437944176910523" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">A practical miniature long-term bone marrow culture system for investigating early myelodysplasia</a><div class="gs_gray">IAG Roberts, MF McMullin</div><div class="gs_gray">Leukemia research 16 (8), 737-741<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15745771632865494688" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Myelodysplasia as the initial presentation of Fanconi's anaemia in a phenotypically normal child</a><div class="gs_gray">MF McMullin, P Mahendra, R Hain, AJ Barrett</div><div class="gs_gray">Clinical &amp; Laboratory Haematology 13 (4), 387-389<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15655291005707992950" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia</a><div class="gs_gray">G Greenfield, R McMullan, N Robson, J McGimpsey, M Catherwood, ...</div><div class="gs_gray">BMC hematology 19 (1), 1-9<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7295260367044909766" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HGTzPopzzJcC" class="gsc_a_at">S1607 MOLECULAR ANALYSIS IN MAJIC PV CORRELATION WITH CLINICAL ENDPOINTS.</a><div class="gs_gray">N Curto-Garcia, J Baxter, E Harris, MF McMullin, A Mead, C Yap, ...</div><div class="gs_gray">Hemasphere 3 (S1), 740<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16352991855827475558" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial</a><div class="gs_gray">C Harrison, A Mead, A Panchal, S Fox, C Yap, A Houlton, S Aliman, ...</div><div class="gs_gray">Ferrata Storti Foundation 101 (S1)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6293408810573470943" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:L1USKYWJimsC" class="gsc_a_at">Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.</a><div class="gs_gray">F Passamonti, S Schnittger, F Girodon, JJ Kiladjian, MF McMullin, ...</div><div class="gs_gray">Blood 114 (22), 3904<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15090997863100557632" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Modification or Dose or Treatment Duration Has No Impact on Outcome of AML in Older Patients: Preliminary Results of the UK NCRI AML14 Trial.</a><div class="gs_gray">AK Burnett, DW Milligan, AG Prentice, AH Goldstone, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 543-543<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4339823236226799496" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms–long term follow-up of a regional case series</a><div class="gs_gray">G Greenfield, MF McMullin</div><div class="gs_gray">Thrombosis journal 16 (1), 1-7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3312843960487954567" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:3htObqc8RwsC" class="gsc_a_at">Equivalence of BCSH and WHO diagnostic criteria for ET</a><div class="gs_gray">CN Harrison, MF McMullin, AR Green, AJ Mead</div><div class="gs_gray">Leukemia 31 (2), 527-528<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11706539373506277148" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:UxriW0iASnsC" class="gsc_a_at">Impact on MPN symptoms and quality of life of front line pegylated interferon alpha-2a vs. hydroxyurea in high risk polycythemia vera and essential thrombocythemia: interim&nbsp;…</a><div class="gs_gray">RA Mesa, R Hoffman, HE Kosiorek, JT Prchal, CN Harrison, MF McMullin, ...</div><div class="gs_gray">Blood 128 (22), 4271<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4540066711241304694" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">A Comparison of Single Dose Gemtuzumab Ozogamicin 3mg/m<sup>2 </sup>and 6mg/m<sup>2</sup> Combined with Induction Chemotherapy in Younger Patients with AML: Data from&nbsp;…</a><div class="gs_gray">AK Burnett, N Russell, RK Hills, J Cavenagh, J Kell, G Jones, A Khwaja, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2308-2308<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3096158397562520377" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Is congenital secondary erythrocytosis/polycythemia caused by activating mutations within the HIF-2α iron-responsive element?</a><div class="gs_gray">MJ Percy, M Sanchez, S Swierczek, MF McMullin, MP Mojica-Henshaw, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (7), 2776-2777<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12694111753113556624" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia</a><div class="gs_gray">MJ Percy, RJG Cuthbert, A May, MF McMullin</div><div class="gs_gray">Journal of clinical pathology 59 (9), 1002-1002<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12778163007591260476" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Should asymptomatic haemochromatosis be treated? Treatment can be onerous for patient and doctorCommentary: False certainty of clinical guidanceCommentary: Early treatment is&nbsp;…</a><div class="gs_gray">CJ Seamark, I Heath, MF McMullin, M Hutchinson</div><div class="gs_gray">Bmj 320 (7245), 1314-1317<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6484071052975434771" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Hydroxycarbamide plus aspirin vs aspirin alone in intermediate risk essential thrombocythemia: results of the PT-1 international, prospective, randomized clinical trial</a><div class="gs_gray">AL Godfrey, PJ Campbell, C MacLean, G Buck, CL East, J Cook, J Temple, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 319-319<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17716732221692149981" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Myeloproliferative Neoplasm Quality of Life (MPN-QOL) study group: results from the MPN experimental assessment of symptoms by utilizing repetitive evaluation (MEASURE) trial</a><div class="gs_gray">A Scotch, RM Scherber, M Bruso, HE Kosiorek, AC Dueck, H Geyer, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 1641-1641<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14081178624345224307" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HE397vMXCloC" class="gsc_a_at">APL of all risk groups is highly curable with a chemo-free combination of attenuated arsenic trioxide and ATRA</a><div class="gs_gray">A Burnett, N Russell, RHA Khwaja, D Bowen, J Cavenagh, LS Friis, J Kell, ...</div><div class="gs_gray">Haematologica 100 (S1), 334<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5963772077067252581" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2l5NCbZemmgC" class="gsc_a_at">How would I manage a case of essential thrombocythaemia presenting with an ischaemic toe</a><div class="gs_gray">DP McLornan, MF McMullin</div><div class="gs_gray">Hematological oncology 26 (1), 3-7<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18168534566242929565" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Erythrocytosis Caused by Mutations in the PHD2 and VHL Genes.</a><div class="gs_gray">MJ Percy, PW Furlow, FGC Jones, TRJ Lappin, FS Lee, MF McMullin</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3663-3663<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1466982509128904439" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HDshCWvjkbEC" class="gsc_a_at">JAK2 exon 12 mutations occur frequently in idiopathic erythrocytosis patients with low serum erythropoietin levels</a><div class="gs_gray">MJ Percy, LM Scott, WN Erber, CN Harrison, JT Reilly, FGC Jones, ...</div><div class="gs_gray">Haematologica 92, 333-334<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2004453568923572414" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Sequence characterisation and expression of homeobox HOX A7 in the multi-potential erythroleukaemic cell line TF-1</a><div class="gs_gray">MA McIlhatton, P Bremner, MF McMullin, AP Maxwell, PC Winter, ...</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1442 (2-3&nbsp;…<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13702695749730019091" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:UmS_249rOGwC" class="gsc_a_at">Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses.</a><div class="gs_gray">AK Burnett, NH Russell, RK Hills, S Knapper, S Freeman, B Huntly, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13136438629639278075" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:27LrP4qxOz0C" class="gsc_a_at">Robust overall survival and sustained efficacy outcomes during long term exposure to momelotinib in JAK inhibitor naïve and previously JAK inhibitor treated intermediate/high&nbsp;…</a><div class="gs_gray">S Verstovsek, M Egyed, E Lech-Marańda, T Sacha, V Dubruille, ST Oh, ...</div><div class="gs_gray">Blood 136, 51-52<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12097643105699582930" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Diagnostic workflow for hereditary erythrocytosis and thrombocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Hematology 2014, the American Society of Hematology Education Program Book&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3381003207198237381" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tYavs44e6CUC" class="gsc_a_at">Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Settings</a><div class="gs_gray">A Yacoub, J Mascarenhas, RA Mesa, HE Kosiorek, RK Rampal, RT Silver, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8425034370119690714" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Somatic SF3B1 mutations in myelodysplastic syndrome with ring sideroblasts and chronic lymphocytic leukaemia</a><div class="gs_gray">A Foy, MF McMullin</div><div class="gs_gray">Journal of clinical pathology 72 (11), 778-782<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4812070919309328569" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat</a><div class="gs_gray">S McPherson, G Greenfield, C Andersen, J Grinfeld, HC Hasselbalch, ...</div><div class="gs_gray">Experimental hematology 79, 26-34<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2267478798229007117" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">A comparison of inpatient and outpatient-based chemotherapy regimens for the treatment of acute myeloid leukaemia in the elderly</a><div class="gs_gray">AB Daly, R Cuthbert, D Finnegan, C Arnold, C Craddock, MF McMullin</div><div class="gs_gray">The Ulster medical journal 88 (1), 25<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5836423487686609212" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:rTD5ala9j4wC" class="gsc_a_at">A two-part study of givinostat in patients with polycythemia vera: the maximum tolerated dose selection and the proof of concept final results</a><div class="gs_gray">A Rambaldi, A Iurlo, AM Vannucchi, R Noble, N von Bubnoff, A Guarini, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 253-253<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18413416382328744400" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hkOj_22Ku90C" class="gsc_a_at">32P in the treatment of myeloproliferative disorders</a><div class="gs_gray">S Lawless, MF McMullin, R Cuthbert, R Houston</div><div class="gs_gray">The Ulster medical journal 85 (2), 83<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6746264766141134610" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">The prevalence of <i>CALR</i> mutations in a cohort of patients with myeloproliferative neoplasms</a><div class="gs_gray">E Grinsztejn, MJ Percy, D McClenaghan, M Quintana, RJG Cuthbert, ...</div><div class="gs_gray">International journal of laboratory hematology 38 (1), 102-106<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9024412243450956326" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">A two-part study of Givinostat in patients with polycythemia vera: maximum tolerated dose definition and preliminary efficacy results</a><div class="gs_gray">G Finazzi, B Martino, A Pezzuto, A Hellmann, MF McMullin, R Noble, ...</div><div class="gs_gray">Blood 128 (22), 4261<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8028315678727859408" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Management of newly diagnosed chronic myeloid leukaemia during a twin pregnancy using leucapheresis: case report and review of the literature</a><div class="gs_gray">A Morris, MF McMullin, G Benson</div><div class="gs_gray">Transfusion and Apheresis Science 52 (2), 199-203<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2371574456799963153" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Outcomes of pregnancy in patients with congenital erythrocytosis.</a><div class="gs_gray">MF McMullin, C Bento, C Rossi, MG Rainey, F Girodon, H Cario</div><div class="gs_gray">British journal of haematology 170 (4), 586-588<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9377929909071987800" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">A phase II study of vorinostat (MK-0683) in patients with polycythemia vera and essential thrombocythemia</a><div class="gs_gray">CL Andersen, MF McMullin, E Ejerblad, S Zweegman, CN Harrison, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 803-803<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13087199079218322059" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">A phase Ib, open-label, dose-finding study of ruxolitinib in patients (pts) with primary myelofibrosis (PMF), post-polycythemia vera-myelofibrosis (PPV-MF), or post-essential&nbsp;…</a><div class="gs_gray">H Gisslinger, MF McMullin, N Jaekel, CB Miller, S Verstovsek, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (15_suppl), TPS6642-TPS6642<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=701844608418819977" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Tumour lysis syndrome after splenic irradiation in a patient with JAK2 V617F post-polycythaemia vera myelofibrosis</a><div class="gs_gray">S Jain, C Harrison, MF McMullin, RF Houston</div><div class="gs_gray">Clinical Oncology 22 (10), 893<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15933636965517386657" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Idiopathic pure red cell aplasia: first report on CD8 positive lymphocytosis in bone marrow biopsy sections</a><div class="gs_gray">KMA Ramadan, JAM Anderson, MF McMullin, GM Markey</div><div class="gs_gray">Journal of clinical pathology 58 (10), 1118-1120<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14531070040690845152" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:otzGkya1bYkC" class="gsc_a_at">Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis</a><div class="gs_gray">P Windrum, FGC Jones, MF McMullin</div><div class="gs_gray">Bone marrow transplantation 34 (3), 281-282<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13566334409393379455" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Selective block in erythropoietin-induced differentiation of growth factor-independent retrovirally-infected TF-1 cells</a><div class="gs_gray">MJ Percy, TRJ Lappin, OM Buckley, MF McMullin</div><div class="gs_gray">Leukemia research 21 (7), 657-666<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14426524308981933668" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Pneumocystis prophylaxis after bone marrow transplantation for severe aplastic anaemia</a><div class="gs_gray">A BASHEY, MF McMullin, JM Hows</div><div class="gs_gray">Bone marrow transplantation (Basingstoke) 5 (4), 285-285<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11149896629105813807" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mel-f30kHHgC" class="gsc_a_at">Effects of tamoxifen on the mutant allele burden and disease course in patients with myeloproliferative neoplasms-results of the TAMARIN study</a><div class="gs_gray">C Harrison, J Baxter, RH Boucher, T McKerrell, A Jackson, RS Fletcher, ...</div><div class="gs_gray">Blood 136, 33-35<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5448629515300768043" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Acute promyelocytic leukaemia (APML) with cryptic <i>PML‐RARA</i> fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation</a><div class="gs_gray">G Greenfield, O Michail, B Merron, J McGimpsey, M Catherwood, ...</div><div class="gs_gray">British journal of haematology 186 (1), 155-157<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3064081454027943408" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Facing erythrocytosis: Results of an international physician survey.</a><div class="gs_gray">E Rumi, MF McMullin, C Harrison, MH Ellis, M Barzilai, N Sarid, R Mesa, ...</div><div class="gs_gray">American journal of hematology 94 (9), E225-E227<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14227560712223351979" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_B80troHkn4C" class="gsc_a_at">The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples</a><div class="gs_gray">G James, MF McMullin, AS Duncombe, M Clarke, LA Anderson</div><div class="gs_gray">Annals of human genetics 82 (2), 114-118<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6145654046164822275" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Personalized prognostic predictions for Patients with myeloproliferative neoplasms through integration of comprehensive genomic and clinical information</a><div class="gs_gray">J Grinfeld, J Nangalia, EJ Baxter, AL Godfrey, P Guglielmelli, R Cantrill, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 491-491<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3479664990537996626" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Higher dose daunorubicin appears beneficial in patients harbouring a FLT3-ITD mutation: Updated results of the UK NCRI AML17 trial</a><div class="gs_gray">N Russell, R Hills, J Cavenagh, L Kjeldsen, M McMullin, P Cahalin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5448659489634835331" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: results of the UK Trials Acceleration&nbsp;…</a><div class="gs_gray">C Craddock, AE Houlton, P Ferguson, M Raghavan, S Fox, L Dudley, ...</div><div class="gs_gray">Blood 128 (22), 1065<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=52392318097309488" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Altered methylation levels in elderly acute myeloid leukaemia patients compared to elderly well individuals</a><div class="gs_gray">M Dellett, HAA Colyer, KA Pettigrew, MF McMullin, IM Rea, KI Mills</div><div class="gs_gray">British journal of haematology 161 (2), 294-296<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=812777993662120899" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Management of myelofibrosis: a survey of current practice in the United Kingdom</a><div class="gs_gray">MR Qureshi, C MacLean, MF McMullin, C Harrison</div><div class="gs_gray">Journal of clinical pathology 65 (12), 1124-1127<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6791423361311394482" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-95Q15plzcUC" class="gsc_a_at">Analysis of the GeneXpert System on the International Multicentre ICORG 08–02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase&nbsp;…</a><div class="gs_gray">ME O'Dwyer, R Swords, F Giles, MF McMullin, PD le Coutre, A Nagler, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 3774-3774<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17046613426029875676" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Systematic evaluation of DNA-based quantitative-polymerase chain reaction (Q-PCR) assays to track treatment response in patients with JAK2-V617F associated myeloproliferative&nbsp;…</a><div class="gs_gray">JV Jovanovic, AM Vannucchi, E Lippert, EO Leibundgut, N Maroc, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2812-2812<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5949146429292515518" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:8AbLer7MMksC" class="gsc_a_at">The finding of a reciprocal whole-arm translocation t (X; 12)(p10; p10) in association with atypical chronic myeloid leukaemia</a><div class="gs_gray">PT Elder, MF McMullin, MW Humphreys, J Hamilton, P McGrattan</div><div class="gs_gray">Medical Oncology 27 (3), 760-762<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5154034198607123164" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel+ 13,+ 15 double trisomy resulting in an&nbsp;…</a><div class="gs_gray">P McGrattan, M Humphreys, D Hull, MF McMullin</div><div class="gs_gray">The Ulster medical journal 76 (3), 131<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7896441552923153537" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">HOXA6: A novel candidate gene in AML.</a><div class="gs_gray">GJ McGonigle, DPJ Finnegan, MF McMullin, TRJ Lappin, A Thompson</div><div class="gs_gray">Blood 108 (11), 2312<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6075828098223532496" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Mutations in the VHL gene are the major identified cause of inherited erythrocytosis.</a><div class="gs_gray">MJ Percy, FGC Jones, TRJ Lappin, MF McMullin</div><div class="gs_gray">Blood 106 (11), 569<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9957901754330757523" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Survival from Acute MyeloidLeukaemia in Patients Over 55 Years of Age in Northern Ireland: A Discrete Population</a><div class="gs_gray">MF McMullin, G MacKenzie</div><div class="gs_gray">Hematology 6 (2), 103-110<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6787854692411609806" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:f2IySw72cVMC" class="gsc_a_at">Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion.</a><div class="gs_gray">D Craig, IS Cadden, WP Gormley, MS Riley, FG Jones, MF McMullin</div><div class="gs_gray">International journal of clinical practice 54 (3), 194-196<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4023981109145212871" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">Is excessive spontaneous intramedullary apoptosis unique to myelodysplasia?(multiple letters)[1]</a><div class="gs_gray">SD Mundle, VT Shetty, A Raza, AE Irvine, MF McMullin</div><div class="gs_gray">Experimental hematology 26 (11), 1014-1017<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9557823168406856118" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:L_l9e5I586QC" class="gsc_a_at">Heparin induced thrombocytopenia causing life-threatening postoperative haemorrhage.</a><div class="gs_gray">P Rice, S Dace, MF McMullin, WD Clements</div><div class="gs_gray">The British journal of clinical practice 50 (7), 404-405<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5159128868213025398" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Molecular pathogenesis of the myeloproliferative neoplasms</a><div class="gs_gray">G Greenfield, MF McMullin, K Mills</div><div class="gs_gray">Journal of Hematology &amp; Oncology 14 (1), 1-18<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18179140950092071435" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Genetic Background of Congenital Erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Genes 12 (8), 1151<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1202564718043944706" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Xz60mAmATU4C" class="gsc_a_at">MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic</a><div class="gs_gray">S Verstovsek, CC Chen, M Egyed, M Ellis, L Fox, YT Goh, V Gupta, ...</div><div class="gs_gray">Future Oncology 17 (12), 1449-1458<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4348629814610752841" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide</a><div class="gs_gray">O Chowdhury, J O’Sullivan, N Barkas, G Wang, G Buck, A Hamblin, ...</div><div class="gs_gray">Leukemia 35 (4), 1197-1202<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13129717768238618231" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm</a><div class="gs_gray">RA Salisbury, N Curto-Garcia, J O’Sullivan, F Chen, P Polzella, ...</div><div class="gs_gray">Leukemia, 1-7<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7125555228755687861" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study</a><div class="gs_gray">D Milojkovic, NCP Cross, S Ali, J Byrne, G Campbell, FL Dignan, ...</div><div class="gs_gray">British journal of haematology 192 (1), 62-74<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7365685511944772202" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:jSAVyFp_754C" class="gsc_a_at">Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort</a><div class="gs_gray">O Michail, P McCallion, J McGimpsey, A Hindley, G Greenfield, J Feerick, ...</div><div class="gs_gray">Journal of Clinical Pathology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13639052152630406239" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Aetiology of Myeloproliferative Neoplasms</a><div class="gs_gray">MF McMullin, LA Anderson</div><div class="gs_gray">Cancers 12 (7), 1810<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5846752275284117500" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:8k81kl-MbHgC" class="gsc_a_at">The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells</a><div class="gs_gray">K Clarke, C Young, F Liberante, MF McMullin, A Thompson, K Mills</div><div class="gs_gray">Oncotarget 10 (37), 3462<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=996554414243406169" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.</a><div class="gs_gray">RR McMullan, C McConville, MF McMullin</div><div class="gs_gray">The Ulster medical journal 88 (2), 105<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2441619660897128241" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Absence of CALR mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels</a><div class="gs_gray">MA Catherwood, A Graham, RJG Cuthbert, C Garrec, B Gardie, F Girodon, ...</div><div class="gs_gray">Acta haematologica 139 (4), 217-219<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18122383325716265404" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Management of hyperkalaemia</a><div class="gs_gray">M Bridgham, S Curran, MF McMullin</div><div class="gs_gray">The journal of the Royal College of Physicians of Edinburgh 44 (1), 91-92<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4158020437475289122" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Anemia and the Use of Erythropoietic-Stimulating Agents with Ruxolitinib in the COMFORT-II Study</a><div class="gs_gray">MF McMullin, CN Harrison, D Niederwieser, H Demuynck, N Jäckel, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 5147-5147<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17257806784303808747" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Increased <i>MSI2</i> expression Is Associated with Aggressive CML and AML</a><div class="gs_gray">JS Kaeda, KI Mills, MG Kharas, G Saglio, M Schwarz, C Oberender, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2516-2516<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8453622371771584865" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">Low Dose Ara-C Versus Low Dose Ara-C and Arsenic Trioxide: the UK NCRI AML16 “Pick a Winner” Comparison.</a><div class="gs_gray">NH Russell, RK Hills, AE Hunter, D Milligan, WJ Kell, K Wheatley, ...</div><div class="gs_gray">Blood 114 (22), 486<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18101992177338754813" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:artPoR2Yc-kC" class="gsc_a_at">The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.</a><div class="gs_gray">NCP Cross, P Campbell, PA Beer, S Schnittger, AM Vannucchi, K Zoi, ...</div><div class="gs_gray">Blood 114 (22), 433<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12694349194654257058" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Developing an Online Video Lecture Series: eLearning for Undergraduate Medical Students</a><div class="gs_gray">J James, MF McMullin, K McGlade</div><div class="gs_gray">E-Learn: World Conference on E-Learning in Corporate, Government, Healthcare&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7841266349855087841" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Allogeneic Bone Marrow Transplant in Belfast–An outcome overview of the first 25 years</a><div class="gs_gray">CA Cargo, E Yates, C Marley, S Piggott, MF McMullin, FGC Jones</div><div class="gs_gray">The Ulster medical journal 77 (3), 185<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1420568327355983199" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Transfusion in the management of patients with megaloblastic anaemia.</a><div class="gs_gray">MF McMullin, RJ Cuthbert</div><div class="gs_gray">International journal of clinical practice 53 (2), 104-106<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10042180114308324186" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Therapy with recombinant erythropoietin in paroxysmal nocturnal haemoglobinuria</a><div class="gs_gray">MF McMullin, P Hillmen, GE Elder, T Lappin, L Luzzatto</div><div class="gs_gray">British journal of haematology 94, 424-424<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3456643053081340686" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YohjEiUPhakC" class="gsc_a_at">Postsplenectomy sepsis: a lifelong risk.</a><div class="gs_gray">J Nelson, MF McMullin</div><div class="gs_gray">The Ulster medical journal 62 (2), 166<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9817135571210808858" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">Longitudinal and individual symptom analyses of momelotinib and ruxolitinib treated myelofibrosis patients from SIMPLIFY-1.</a><div class="gs_gray">RA Mesa, S Hudgens, L Floden, J Palmer, V Gupta, DP Mclornan, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (15_suppl), e19040-e19040<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18367572145238645335" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program</a><div class="gs_gray">A Rambaldi, A Iurlo, AM Vannucchi, B Martino, A Guarini, M Ruggeri, ...</div><div class="gs_gray">Blood cancer journal 11 (3), 1-7<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12616984616808377213" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">CPI-0610, bromodomain and extraterminal domain protein (BET) inhibitor, as' add-on'to ruxolitinib, in advanced myelofibrosis patients with suboptimal response: update of&nbsp;…</a><div class="gs_gray">TCP Somervaille, S Verstovsek, J Mascarenhas, M Kremyanskaya, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4686763588279300727" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms</a><div class="gs_gray">G Greenfield, S McPherson, J Smith, A Mead, C Harrison, K Mills, ...</div><div class="gs_gray">Cancers 12 (9), 2669<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6396822336920837325" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">A molecular diagnostic algorithm for JAK2 V617F investigations in suspected myeloproliferative neoplasms</a><div class="gs_gray">MA Catherwood, R McAllister, P McCallion, JE McGimpsey, A Hindley, ...</div><div class="gs_gray">Irish Journal of Medical Science (1971-) 189 (2), 621-626<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1337428794700225287" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls</a><div class="gs_gray">V De Stefano, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9510060596592449460" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">risk factors for secondary cancer in a case-control study on 1,259 patients with myeloproliferative neoplasms</a><div class="gs_gray">T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">Blood 132, 4279<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1599893640245911277" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mKu_rENv82IC" class="gsc_a_at">A spotlight on the management of complications associated with myeloproliferative neoplasms: a clinician’s perspective</a><div class="gs_gray">G Greenfield, MF McMullin</div><div class="gs_gray">Expert review of hematology 11 (1), 25-35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16814333114554006672" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kF1pexMAQbMC" class="gsc_a_at">70 years of the JCP-highly cited papers: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Journal of clinical pathology 70 (11), 909-910<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17807495360224877349" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network.</a><div class="gs_gray">M Griffin, I Neilly, M Nikolousis, S Narayanan, K Lowndes, M Koh, J Ros, ...</div><div class="gs_gray">British journal of haematology 182 (6), 930-933<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7347085416057998210" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">A two-part study of givinostat in patients with polycythemia vera: maximum tolerated dose definition and preliminary efficacy results</a><div class="gs_gray">M McMullin, G Finazzi, AM Vannucchi, R Mesa</div><div class="gs_gray">58th Annual Meeting &amp; Exposition<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7729289667548414497" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:bnK-pcrLprsC" class="gsc_a_at">PHENOTYPIC DIFFERENCES AND TREATMENT RESPONSES IN MOLECULAR SUBGROUPS OF ESSENTIAL THROMBOCYTHEMIA FROM ANALYSIS OF THE PT1 COHORT</a><div class="gs_gray">J Nangalia, A Jones, A Godfrey, C MacLean, P Beer, A Bench, F Nice, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 8-8<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5840476984029506179" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uVUOdF_882EC" class="gsc_a_at">Assessment and validation of the EQ-5D among a population of myeloproliferative neoplasm patients</a><div class="gs_gray">RM Scherber, S Knapper, S Fox, HE Kosiorek, M Shah, S Abdi-Moradi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 5179-5179<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17104823664319067620" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PELIpwtuRlgC" class="gsc_a_at">A comparison of 1 or 2 courses of high dose cytarabine as consolidation in younger patients with AML: first results of the UK NCRI AML17 trial</a><div class="gs_gray">NH Russell, RK Hills, S Freeman, S Knapper, L Kjeldsen, I Thomas, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 221-221<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6202147045860485284" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study</a><div class="gs_gray">MF McMullin, G James, AS Duncombe, F De Vocht, L Fritschi, M Clarke, ...</div><div class="gs_gray">Experimental hematology &amp; oncology 5 (1), 1-5<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3198367585505315138" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">VORINOSTAT MAY OFFER LONG TERM CONTROL OF DISEASE IN THERAPY RESISTANT ESSENTIAL THROMBOCYTHAEMIA</a><div class="gs_gray">S Alimam, D Radia, MF McMullin, H Hasselbalch, CL Andersen, ...</div><div class="gs_gray">Haematologica 100, 753-754<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1795964623325780312" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:KaMxkj08jr0C" class="gsc_a_at">A randomised assessment of vosaroxin and vosaroxin combined with low dose Ara-C (LDAC) versus low dose Ara-C alone in older patients with acute myeloid leukemia.</a><div class="gs_gray">M Dennis, N Russell, R Hills, C Hemmaway, N Panoskaltsis, M McMullin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16104992110345446143" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:i2xiXl-TujoC" class="gsc_a_at">A Japanese Family with Congenital Erythrocytosis Caused by Haemoglobin Bethesda</a><div class="gs_gray">S Tamura, T Tamura, H Gima, A Nishikawa, Y Okamoto, N Kanazawa, ...</div><div class="gs_gray">Internal Medicine 54 (18), 2389-2393<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8913122812671567281" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Update in the myeloproliferative neoplasms</a><div class="gs_gray">CN Harrison, MF McMullin</div><div class="gs_gray">Clinical Medicine 14 (Suppl 6), s66-s70<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3275994488957583122" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">MOSAICC Study</a><div class="gs_gray">GJ Titmarsh, LA Anderson, MF McMullin, A Duncombe, L Fritschi, R Mesa, ...</div><div class="gs_gray">European School of Hematology International Conference on Myeloproliferative&nbsp;…<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12134899378249561965" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Symptom Burden Among PV and ET Patients Receiving A Novel Histone Deacetylase Inhibitor: Findings From a Open-Label Phase II Study</a><div class="gs_gray">CL Andersen, MF McMullin, RM Emanuel, AC Dueck, D Bareford, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1736-1736<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7572331643798072877" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:qUcmZB5y_30C" class="gsc_a_at">A PHASE 1B, OPEN-LABEL, DOSE-FINDING STUDY OF RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND BASELINE PLATELET (PLT) COUNTS BETWEEN 50 AND&lt; 100 X 109/L</a><div class="gs_gray">H Gisslinger, M McMullin, N Jakel, C Miller, S Verstovsek, C Harrison, ...</div><div class="gs_gray">Haematologica 97, 149-149<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1913010005007440487" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">A Novel Base Change Leading to Hb Vanderbilt [β89(F5)Ser→Arg, AG<i>T</i>&gt;AG<i>A</i>]</a><div class="gs_gray">MJ Goodyer, EI Elhassadi, MJ Percy, MF McMullin</div><div class="gs_gray">Hemoglobin 35 (4), 428-429<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=376392199314982423" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Diagnosis and Treatment of Erythrocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Journal-Diagnosis and Treatment of Erythrocytosis<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1460230288161313934" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">TWO ROUTES TO LEUKAEMIC TRANSFORMATION FOLLOWING A JAK2 MUTATION-POSITIVE MYELOPROLIFERATIVE NEOPLASM</a><div class="gs_gray">PA Beer, F Delhommeau, JP Lecouedic, D Bareford, R Kukec, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 421-421<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4471812264871280794" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:evX43VCCuoAC" class="gsc_a_at">The prognostic role of c-FLIP in AML</a><div class="gs_gray">P McLornan, MF McMullin, KI Mills, RK Hills, AF Gilkes, AK Burnett, ...</div><div class="gs_gray">Haematologica 94 (S2), 108<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7175863215380951466" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">HIF-2alpha Associated Familial Erythrocytosis Supports the PHD2-HIF-2alpha-VHL Axis as the Major Regulator of Erythropoietin Production</a><div class="gs_gray">M Percy, PW Furlow, PA Beer, G Campbell, AW Dekker, AR Green, X Li, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 481-481<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12813526707991023007" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">A novel Arg371His Mutation in the HIF prolyl hydroxylase PHD2 is associated with erythrocytosis</a><div class="gs_gray">MJ Percy, PW Furlow, PA Beer, T Lappin, MF McMullin, FS Lee</div><div class="gs_gray">Haematologica 92, 87-87<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9490578158267469837" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Familial erythrocytosis associated with a mutation in the HIF prolyl hydroxylase, PHD2.</a><div class="gs_gray">MJ Percy, Q Zhao, A Flores, CN Harrison, TRJ Lappin, PH Maxwell, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 127-127<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15277577302304318217" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:k_IJM867U9cC" class="gsc_a_at">Bone marrow architecture in acute myeloid/erythroid leukaemia</a><div class="gs_gray">SM McCloskey, MF McMullin, TCM Morris, GM Markey</div><div class="gs_gray">British journal of haematology 126 (1), 1-1<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2648603823192365339" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Novel uses for recombinant erythropoietin therapy in unlicensed indications</a><div class="gs_gray">CA Macartney, AAJ Adgey, FGC Jones, TCM Morris, MF McMullin</div><div class="gs_gray">The Hematology Journal 5 (2), 181-185<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5312397436717312262" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Identification of the Chuvash-type congenital polycythemia in patients of Asian and western European ancestry.</a><div class="gs_gray">MJ Percy, MF McMullin, M Treacy, M Potter, WH Watson, SN Jowitt, ...</div><div class="gs_gray">Blood 100, 660A-661A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7438434078078151098" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Survival 15 years post nonmyeloablative bone marrow transplant in a patient with frank relapse of acute myeloid leukaemia and severe psoriasis</a><div class="gs_gray">P Windrum, M McMullin, D Campbell, F Jones</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 29, S158-S158<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17105534132973871818" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">THE ASSESSMENT OF BCL-2 AND BAX IN ACUTE MYELOID LEUKAEMIA: A COMPARISON OF IMMUNOCYTOCHEMISTRY AND REAL-TIME PCR.</a><div class="gs_gray">Y Ong, M McMullin, F Jones, T Lappin, A Irvine</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16176140278136425713" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:fEOibwPWpKIC" class="gsc_a_at">SMALL ARRAY REAL TIME (SMART) QUANTITATIVE PCR PROFILING OF HOX GENES IN AML AND ALL PATIENTS.</a><div class="gs_gray">A Thompson, M Ahmed, M Quinn, M McMullin, F Cotter, T Lappin</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7216688459190677884" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Smart quantitative PCR profiling of HOX gene expression: Application to pathogenesis and treatment monitoring of leukemia.</a><div class="gs_gray">A Thompson, MR Ahmed, CM O'Neill, MF McMullin, T Lappin, FE Cotter</div><div class="gs_gray">Blood 96, 311A-311A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17538553416057059226" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Erythrocytosis caused by the Finnish-type erythropoietin receptor mutation.</a><div class="gs_gray">MJ Percy, MF McMullin, A Roques, N Westwood, J Acharya, T Lappin, ...</div><div class="gs_gray">Blood 88, 2781-2781<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7549417172365680176" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:lvd772isFD0C" class="gsc_a_at">Retroviral-mediated gene transfer of the human erythropoietin gene into a factor-dependent cell line, TF-1.</a><div class="gs_gray">MJ Percy, PC Winter, TR Lappin, MF McMullin</div><div class="gs_gray">Leukemia 9, S66-9<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12555089292667842637" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Increased intramedullary apoptosis may contribute to the peripheral cytopenias observed in MDS</a><div class="gs_gray">AE Irvine, LE Somerville, S Roddy, MF McMullin</div><div class="gs_gray">BONE MARROW TRANSPLANTATION-BASINGSTOKE- 15, S20-S20<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18352630376143116444" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">SCREENING FOR ERYTHROPIETIN RECEPTOR MUTATIONS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS</a><div class="gs_gray">MJ Percy, PC Winter, TRJ Lappin, MF McMullin</div><div class="gs_gray">Experimental Hematology 23, 765-765<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9590928241234191917" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Circulating CFU-GM are selectively and severely reduced in neutropenic neonates of hypertensive mothers</a><div class="gs_gray">IAG ROBERT, S Hindawi, MF McMullin, N Murray</div><div class="gs_gray">EXPERIMENTAL HEMATOLOGY 20 (6), 801-801<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17616536063052399492" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Systemic mastocytosis with an abnormally expanded T-cell clone</a><div class="gs_gray">MF McMullin, M Chapple, T Vulliamy, J Adams, A Gordon, DM Swirsky, ...</div><div class="gs_gray">Leukemia &amp; Lymphoma 6 (4-5), 419-422<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6239758323471768487" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YB4bud6kWLwC" class="gsc_a_at">MPN-303: Longitudinal and Individual Symptom Analyses from the SIMPLIFY-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK&nbsp;…</a><div class="gs_gray">R Mesa, S Hudgens, L Floden, J Palmer, V Gupta, D McLornan, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 21, S360<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RtRctb2lSbAC" class="gsc_a_at">Poster: MPN-303: Longitudinal and Individual Symptom Analyses from the SIMPLIFY-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in&nbsp;…</a><div class="gs_gray">R Mesa, S Hudgens, L Floden, J Palmer, V Gupta, D McLornan, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 21, S231<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">Hereditary thrombocytosis: the genetic landscape</a><div class="gs_gray">EY Han, M Catherwood, MF McMullin</div><div class="gs_gray">British Journal of Haematology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to&nbsp;…</a><div class="gs_gray">R Mesa, S Hudgens, L Floden, J Palmer, V Gupta, DP McLornan, ...</div><div class="gs_gray">Value in Health 24, S22<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Protein tyrosine phosphatase receptor type C (PTPRC or CD45)</a><div class="gs_gray">MA Al Barashdi, A Ali, MF McMullin, K Mills</div><div class="gs_gray">Journal of Clinical Pathology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">The molecular landscape of acute myeloid leukaemia in Northern Ireland</a><div class="gs_gray">G Greenfield, A Waterworth, N Anderson, J Mcgimpsey, A Hindley, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 193, 79-80<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-yGd096yOn8C" class="gsc_a_at">A Machine Learning Approach to Predicting MPN Patients</a><div class="gs_gray">G Greenfield, J Blayney, MF McMullin, K Mills</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 193, 61-61<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Genetic Background of Congenital Erythrocytosis. Genes 2021, 12, 1151</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">s Note: MDPI stays neutral with regard to jurisdictional claims in published&nbsp;…<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Presidential address to the Ulster Medical Society on 3rd October 2019</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">The Ulster Medical Journal 89 (2), 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">19 Courses of CPX-351 for the treatment of AML</a><div class="gs_gray">S Boyd, MF McMullin</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 189-190<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Ruxolitinib in myelofibrosis: a multicentre analysis of real-world patients in England, Northern Ireland and Wales</a><div class="gs_gray">J Russell, C Wright, D Sparksman, D Waddell, A Daly, R Fisken, A Dicu, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 81-82<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Could CD45 have a role in the development of myeloid malignancies?</a><div class="gs_gray">M Al Barashdi, A Ali, MF McMullin, K Mills</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 183-184<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Ruxolitinib: gaining more than intended</a><div class="gs_gray">G Greenfield, MF McMullin</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 135 (13), 983-984<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Diagnostics in the Future</a><div class="gs_gray">MF McMullin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:EYYDruWGBe4C" class="gsc_a_at">PS1182 REAL WORLD TYROSINE KINASE INHIBITOR TREATMENT PATHWAYS, MONITORING PATTERNS AND RESPONSES COMPARED WITH ELN RECOMMENDATIONS IN CHRONIC MYELOID LEUKAEMIA: FINAL ANALYSIS&nbsp;…</a><div class="gs_gray">D Milojkovic, NC Cross, S Ali, JL Byrne, G Campbell, FL Dignan, L Fildes, ...</div><div class="gs_gray">HemaSphere 3 (S1), 538-539<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:JQOojiI6XY0C" class="gsc_a_at">PB2212 FACING ERYTHROCYTOSIS: RESULTS OF AN INTERNATIONAL PHYSICIANS’SURVEY</a><div class="gs_gray">E Rumi, MF McMullin, C Harrison, MH Ellis, M Barzilai, N Sarid, R Mesa, ...</div><div class="gs_gray">HemaSphere 3 (S1), 992<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">PS1468 IMPACT OF CYTOREDUCTIVE DRUGS ON SECOND CANCER IN MYELOPROLIFERATIVE NEOPLASMS</a><div class="gs_gray">T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ...</div><div class="gs_gray">HemaSphere 3 (S1), 667-668<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Hepatobiliary and Pancreatic: Pyoderma gangrenosum of the pancreas successfully treated with infliximab</a><div class="gs_gray">N Deprez, F Dedeurwaerdere, L Desomer, D De Wulf</div><div class="gs_gray">Journal of gastroenterology and hepatology 34 (5), 816-816<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline (vol 184, pg 176, 2019)</a><div class="gs_gray">MF McMullin, CN Harrison, S Ali, C Cargo, F Chen, J Ewing, M Garg, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185 (1), 198-198<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Mutational profiling in triple-negative essential thrombocythaemia with targeted next-generation sequencing</a><div class="gs_gray">O Michail, M Catherwood, R Cuthbert, C Arnold, R McAllister, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 185, 59-60<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Steckbrief Forschung</a><div class="gs_gray">M Swaminathan, KP Patel, J Huynh-Lu, G Tang, Z Zuo, R Miranda, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 169-170<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:GFxP56DSvIMC" class="gsc_a_at">PharmaNews</a><div class="gs_gray">M Swaminathan, KP Patel, J Huynh-Lu, G Tang, Z Zuo, R Miranda, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 178-182<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0N-VGjzr574C" class="gsc_a_at">Ansprechen auf Imatinib ist bei chronischer myeloischer Leukämie mit BCR-ABL1-Transkriptvariante e13a2 schlechter als bei Transkriptvariante e14a2</a><div class="gs_gray">G Greenfield, R McMullan, N Robson, J McGimpsey, M Catherwood, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 135-142<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:z_wVstp3MssC" class="gsc_a_at">Anforderungen an ein modernes CML-Management</a><div class="gs_gray">M Swaminathan, KP Patel, J Huynh-Lu, G Tang, Z Zuo, R Miranda, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 176-177<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Wissenschaftlicher Beirat/Impressum/Inhalt</a><div class="gs_gray">M Swaminathan, KP Patel, J Huynh-Lu, G Tang, Z Zuo, R Miranda, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 129-133<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Spektrum Onkologie-wissenswert, kompakt, anregend</a><div class="gs_gray">M Swaminathan, KP Patel, J Huynh-Lu, G Tang, Z Zuo, R Miranda, ...</div><div class="gs_gray">Kompass Onkologie 6 (3), 183-186<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial</a><div class="gs_gray">A Gathany, RM Scherber, M Girardo, HE Kosiorek, AC Dueck, H Geyer, ...</div><div class="gs_gray">Blood 132, 1762<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide</a><div class="gs_gray">O Chowdhury, J O'Sullivan, N Barkas, G Buck, A Hamblin, A Tefferi, ...</div><div class="gs_gray">Blood 132, 3037<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work</a><div class="gs_gray">I Jean-Christophe, JJ Kiladjian, M Sobas, P Sadjadian, LY Shih, ...</div><div class="gs_gray">Blood 132, 1759<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Longitudinal Mutational Analysis in Hydroxycarbamide-Resistant/Intolerant Essential Thrombocythemia Treated on the Majic-ET Study</a><div class="gs_gray">J O'Sullivan, A Hamblin, A Panchal, C Yap, S Fox, S Alimam, HMP Dreau, ...</div><div class="gs_gray">Blood 132, 1784<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features</a><div class="gs_gray">GA Buck, AL Godfrey, PJ Campbell, C MacLean, J Cook, J Temple, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (34)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial</a><div class="gs_gray">S McPherson, A Mead, M McMullin, C Harrison, K Mills</div><div class="gs_gray">British Journal of Haematology 181 (S1)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Feasibility of recruitment of patients withMyeloproliferative Neoplasms into the TAPfunded TAMARIN study</a><div class="gs_gray">C Harrison, S Mendez-Ferrer, A Houlton, M Sirovica, M Drummond, ...</div><div class="gs_gray">John Wiley and Sons, Ltd. 181 (S1)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:URolC5Kub84C" class="gsc_a_at">Ruxolitinib in Myelofibrosis: a multicentre experience in England, Northern Ireland and Wales</a><div class="gs_gray">J Russell, A Daly, R Fisken, A Dicu, J Cunningham, D Sparksman, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 10-10<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Methylation age in Myeloproliferative neoplasm patients as a correlate for disease status, allele burden and therapeutic response</a><div class="gs_gray">S McPherson, H Hasselbalch, C Andersen, MF McMullin, K Mills</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 49-50<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Ruxolitinib in Myelofibrosis; the Northern Ireland experience</a><div class="gs_gray">A Daly, J Russell, C Arnold, M Bowers, K Boyd, R Cuthbert, M El-Agnaf, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 61-62<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Ruxolitinib Induces Changes in Histone Modification Status in Patients Entered into the Majic Clinical Trial</a><div class="gs_gray">S McPherson, CN Harrison, AJ Mead, KI Mills, MF McMullin</div><div class="gs_gray">Blood 130, 5285<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Methylation Age In MPN Patients As A Correlate For Disease Status, Allele Burden And Therapeutic Response</a><div class="gs_gray">M McMullin, S McPherson, K Mills</div><div class="gs_gray">Haematologica 102 (S2)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">A history of haematology: from Herodotus to HIV, Shaun R. McCann</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Irish Journal of Medical Science (1971-) 186 (2), 369-369<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Interim Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE&nbsp;…</a><div class="gs_gray">AH Scotch, RM Scherber, N Zhang, HE Kosiorek, AC Dueck, H Geyer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (22), 5479-5479<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context</a><div class="gs_gray">MF McMullin, C Harrison</div><div class="gs_gray">Journal of the National Comprehensive Cancer Network 14 (12), e1626-e1631<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Coexistence of inversion 16 in chronic myeloid leukaemia in blast crisis</a><div class="gs_gray">MA Catherwood, P McGrattan, S Lawless, C McConville, N Robson, ...</div><div class="gs_gray">Journal of Hematopathology 9 (4), 155-160<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:foquWX3nUaYC" class="gsc_a_at">LIFESTYLE AND MEDICAL RISK FACTORS ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASMS: RESULTS FROM THE PILOT MOSAICC STUDY</a><div class="gs_gray">L Anderson, G James, AS Duncombe, F deVocht, L Fritschi, R Mesa, ...</div><div class="gs_gray">Haematology Association of Ireland Conference<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Minor allele frequency of myeloproliferative neoplasm mutations in the Irish blood donor population</a><div class="gs_gray">GJ Titmarsh, GJ McKay, M Lawler, LA Anderson, MF McMullin</div><div class="gs_gray">Hematological oncology 34 (3), 161-164<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SdhP9T11ey4C" class="gsc_a_at">A history of haematology: from Herodotus to HIV, Shaun R. McCann: Shaun R. McCann, ISBN: 9780198717607, Published: 03 March 2016. Oxford University Press, 256 pages</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Irish journal of medical science<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Paroxysmal nocturnal haemoglobinuria screening practice from UK centres: A report from the UK PNH Network: 35</a><div class="gs_gray">M Griffin, S Couzens, W Ingram, R Karim, M Koh, M Layton, K Lowndes, ...</div><div class="gs_gray">British Journal of Haematology 173, 22-23<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Initial assessment of the undiagnosed patient who has an erythrocytosis, leukocytosis, or thrombocytosis</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Managing Myeloproliferative Neoplasms: A Case-Based Approach, 1<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:O0nohqN1r9EC" class="gsc_a_at">Potential benefit of higher dose daunorubicin in patients harbouring a FLT3-ITD mutation: Updated results of the AML17 trial.</a><div class="gs_gray">N Russell, R Hills, J Kell, J Cavanagh, L Kjeldsen, M McMullin, P Cahalin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Correlation Between Treatment Outcomes, Baseline Characteristics and Molecular Responses in the Majic Study Which Compared Ruxolitinib to Best Available Therapy in Essential&nbsp;…</a><div class="gs_gray">CN Harrison, A Mead, S Fox, A Panchal, C Yap, AE Houlton, S Aliman, ...</div><div class="gs_gray">Blood 128 (22), 1929<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:rmuvC79q63oC" class="gsc_a_at">Paroxysmal Nocturnal Hemoglobinuria screening practice from UK centres: a report from the UK PNH network</a><div class="gs_gray">M Griffin, C Couzens, W Ingram, R Karim, M Koh, M Layton, K Lowndes, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 299-299<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">MYELOPROLIFERATIVE NEOPLASM SYMPTOM BURDEN AND QUALITY OF LIFE: RESULTS FROM THE PILOT MOSAICC STUDY</a><div class="gs_gray">L Anderson, G James, AS Duncombe, R Mesa, R Scherber, A Dueck, ...</div><div class="gs_gray">Haematology Association of Ireland Conference<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Myeloproliferative Neoplasms: An in-Depth Case-Control (MOSAICC) Study</a><div class="gs_gray">MF McMullin, A Duncombe, GJ Titmarsh, F de Vocht, L Fritschi, RA Mesa, ...</div><div class="gs_gray">Blood 126 (23), 1621<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:bKqednn6t2AC" class="gsc_a_at">Conditional Deletion of the Hoxa Cluster in MLL-AF9 Is Incompatible with Leukemia Maintenance</a><div class="gs_gray">LM Kettyle, I Grishagin, GJ Dickson, CE Lebert-Ghali, JJ Bijl, MF McMullin, ...</div><div class="gs_gray">Blood 126 (23), 3630<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:isU91gLudPYC" class="gsc_a_at">Myeloproliferative neoplasms: an in-depth case-control study</a><div class="gs_gray">L Anderson, G James, AS Duncombe, F deVocht, M Clarke, M McMullin</div><div class="gs_gray">ASH-American Society of Hematology 57th Annual Meeting and Exposition<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Erratum: How common are myeloproliferative neoplasms? A systematic review and meta-analysis [Am. J. Hematol. 89: 581-587, 2014</a><div class="gs_gray">GJ Titmarsh, AS Duncombe, MF McMullin, M O'Rorke, R Mesa, ...</div><div class="gs_gray">American Journal of Hematology 90 (9), 850<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">How common are myeloproliferative neoplasms? A systematic review and meta-analysis: This article corrects: How common are myeloproliferative neoplasms? A systematic review and&nbsp;…</a><div class="gs_gray">GJ Titmarsh, AS Duncombe, MF McMullin, M O'Rorke, R Mesa, ...</div><div class="gs_gray">American Journal of Haematology 90 (9), 850<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AYInfyleIOsC" class="gsc_a_at">Myeloproliferative neoplasm patients experience significant symptom burden.</a><div class="gs_gray">G James, M McMullin, AS Duncombe, R Mesa, L Anderson</div><div class="gs_gray">NCIN Cancer Outcomes Conference<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">THE INFLUENCE OF SF3B1 MUTATIONS ON THE RESPONSIVENESS OF BLOOD CANCERS TO MOLECULAR THERAPEUTICS</a><div class="gs_gray">F Liberante, K Lappin, MF McMullin, K Savage, K Mills</div><div class="gs_gray">HAEMATOLOGICA 100, 236-236<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Baseline quality of life and symptom burden characteristics of patients intolerant to hydroxyurea: Preliminary results from the MAJIC Trial: 197</a><div class="gs_gray">R Scherber, M McMullin, A Mead, S Fox, M Shah, S Abdi-Moradi, H Bell, ...</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Feasibility of recruitment of hydroxyurearesistant or intolerant ET and PV patients into the MAJIC study: 196</a><div class="gs_gray">C Harrison, A Mean, S Fox, H Bell, S Aliman, A Green, M Wood, J Ewing, ...</div><div class="gs_gray">British Journal of Haematology 169, 80-81<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">An audit of the initial assessment of aplastic anaemia in a single region: 79</a><div class="gs_gray">A Foy, C McConville, M McMullin</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2ywjKiB__4kC" class="gsc_a_at">MYELOPROLIFERATIVE NEOPLASM SYMPTOM BURDEN AND QUALITY OF LIFE: RESULTS FROM THE PILOT MOSAICC STUDY</a><div class="gs_gray">G James, M McMullin, R Scherber, A Dueck, AS Duncombe, F deVocht, ...</div><div class="gs_gray">20th Congress of the European Hematology Association<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">QUALITY OF LIFE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS COMPARED TO NORMAL INDIVIDUALS-CASE-CONTROL EVIDENCE OF SIGNIFICANT IMPAIRMENT</a><div class="gs_gray">A Duncombe, G Titmarsh, M McMullin, R Mesa, R Scherber, A Dueck, ...</div><div class="gs_gray">HAEMATOLOGICA 100, 100-100<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Continuing Medical Education (CME) Questions</a><div class="gs_gray">AK Burnett, NH Russell, RK Hills, J Kell, J Cavenagh, L Kjeldsen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Myeloproliferative neoplasm patients experience significant symptom burden</a><div class="gs_gray">L Anderson, G Titmarsh, M McMullin, A Duncombe, R Mesa, R Scherber, ...</div><div class="gs_gray">European Journal of Cancer Care 24, 65-65<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Therapeutic Advances in Hematology</a><div class="gs_gray">J Arnason, T Barbour, P Basciano, C Besses, G Bociek, H Bonig, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:qwy9JoKyICEC" class="gsc_a_at">32P in the treatment of myeloproliferative disorders</a><div class="gs_gray">S Lawless, MF McMullin, R Cuthbert, R Houston</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 165, 75-76<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">32P in the treatment of myeloproliferative disorders: 185</a><div class="gs_gray">S Lawless, M McMullin, R Cuthbert, R Houston</div><div class="gs_gray">British Journal of Haematology 165, 75-76<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR–EPOR Chimeras</a><div class="gs_gray">M Gross, N Ben-Califa, HC Hasselbalch, MF McMullin, M Percy, C Bento, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2174-2174<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">JAK2Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study</a><div class="gs_gray">L Kjaer, E Lippert, F Girodon, S Schnittger, S Carillo, C Riley, B Bellosillo, ...</div><div class="gs_gray">Blood 122 (21), 4075<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Cover Figure</a><div class="gs_gray">ES Jaffe, A Engert, AM Carella, S Branford, M Deininger, FX Mahon, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Circulating YKL-40 in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV) treated with the Novel Histone Deacetylase Inhibitor Vorinostat</a><div class="gs_gray">CL Andersen, ME Bjørn, MF McMullin, E Ejerblad, S Zweegman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">A POPULATION STUDY OF OUTCOMES IN CHRONIC MYELOID LEUKAEMIA IN N. IRELAND FROM 2000-PRESENT.</a><div class="gs_gray">C Mcconville, D Finnegan, R Cuthbert, C Arnold, F Mcnicholl, K Boyd, ...</div><div class="gs_gray">HAEMATOLOGICA 98, 563-563<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0izLItjtcgwC" class="gsc_a_at">COMMON COMMUNITY INFECTIONS AND THEIR ASSOCIATION WITH MYELOID MALIGNANCIES</a><div class="gs_gray">G Titmarsh, M McMullin, C McShane, M Clarke, E Engels, L Anderson</div><div class="gs_gray">HAEMATOLOGICA 98, 623-624<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Chronic myeloid leukaemia in Northern Ireland-a population study 2000-Present: 156</a><div class="gs_gray">C McConville, R Thompson, P Windrum, F McNicholl, R Cuthbert, ...</div><div class="gs_gray">British Journal of Haematology 161, 62-63<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Critical importance of the region C terminal to the hydroxyacceptor proline for the regulation of HIF-2alpha</a><div class="gs_gray">M Percy, P Furlow, Y Chung, T Lappin, M McMullin, F Lee</div><div class="gs_gray">American Journal Of Hematology 87 (10)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mUJArPsKIAAC" class="gsc_a_at">ANEMIA AND THE USE OF ERYTHROPOIETIC-STIMULATING AGENTS (ESAS) WITH RUXOLITINIB IN THE COMFORT-II STUDY</a><div class="gs_gray">MF McMullin, C Harrison, D Niederwieser, H Demuynck, N Jaekel, ...</div><div class="gs_gray">HAEMATOLOGICA 97, 157-157<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">This fascinating and carefully worked out case study describes a boy originally presenting with cyanosis at the age of 4 years.</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Clinical Chemistry 58 (2), 335-335<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Critical Issues About the Diagnosis of Myeloproliferative Neoplasms: World Health Organization Classification</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Myeloproliferative Neoplasms, 37-45<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:a0OBvERweLwC" class="gsc_a_at">Therapeutic Potential of Targeted HOXA-TALE Knockdown in AML</a><div class="gs_gray">GJ Dickson, KA O'Hagan, DPJ Finnegan, MF McMullin, KI Mills, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 3460-3460<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">First Achievements of MPN&amp;MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and&nbsp;…</a><div class="gs_gray">S Hermouet, E Lippert, N Pallisgaard, J Schwarz, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2809-2809<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:e_rmSamDkqQC" class="gsc_a_at">An unusual cancer of the thyroid bed</a><div class="gs_gray">CM McHenry, MF McMullin, KR Mullan</div><div class="gs_gray">IRISH JOURNAL OF MEDICAL SCIENCE 180, S505-S505<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:EkHepimYqZsC" class="gsc_a_at">Aberrant expressions of haemostatic genes in granulocytes of chronic myeloproliferative disorders-polycythaemia vera [PV] and essential thrombocythaemia [ET]</a><div class="gs_gray">L Kannan, MF McMullin, P Winter</div><div class="gs_gray">International Journal of Pharma and Bio Sciences 2 (4), 329-334<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Characteristics and outcomes of adult haematology patients admitted to ICU</a><div class="gs_gray">C McCaughey, B Blackwood, M Glackin, M Brady, MF McMullin</div><div class="gs_gray">16th Congress of the European Haematology Association<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Snippets in haematology</a><div class="gs_gray">S McCloskey, MF McMullin</div><div class="gs_gray">Journal of Clinical Pathology 64 (5), 451-455<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Short running title: MPD associated JAK2 V617F is insensitive to SOCS3</a><div class="gs_gray">M McMullin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Protecting donors: a concept analysis of moral distress in potential sibling stem cell donors</a><div class="gs_gray">S Piggott, R Henry, MF McMullin</div><div class="gs_gray">Bone Marrow Transplantation 46 (Suppl 1), S397-S397<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Presentation of the MPN&amp;MPNr-EuroNet (COST Action BM0902)</a><div class="gs_gray">K Hussein, N Pallisgaard, E Lippert, A Vannucchi, J Schwarz, S Schnittger, ...</div><div class="gs_gray">Onkologie 34, 144-144<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:umqufdRvDiIC" class="gsc_a_at">British Society of Haematology, Slide Session presented at the Annual Scientific Meeting, Brighton 2009</a><div class="gs_gray">DP McLORNAN, J Burthem, A Duncombe, C Hatton, CV Hutchinson, ...</div><div class="gs_gray">International journal of laboratory hematology 32 (6p2), 616-624<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:u_35RYKgDlwC" class="gsc_a_at">SOCS3 Phosphorylation In Myeloproliferative Neoplasms</a><div class="gs_gray">C Arnold, J Elliott, JA Johnston, MF McMullin</div><div class="gs_gray">Blood 116 (21), 3083<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">POC07 Central nervous graft-vs-host disease causing intracranial vasculopathy</a><div class="gs_gray">S Kearney, AJ Fulton, MF McMullin, E McKenna</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 81 (11), e36-e36<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SP6oXDckpogC" class="gsc_a_at">Snippets in haematology</a><div class="gs_gray">S McCloskey, MF McMullin</div><div class="gs_gray">Journal of Clinical Pathology 63 (11), 1035-1039<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:p2g8aNsByqUC" class="gsc_a_at">British Society for Haematology, slide session, annual scientific meeting, Glasgow, 2008</a><div class="gs_gray">CV Hutchinson, J Burthem, M Bisland, P Carey, G Crotty, V Devalia, ...</div><div class="gs_gray">International journal of laboratory hematology 32 (2), 174-183<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">VARIABLE RESPONSE TO ASPIRIN IN HEALTHY INDIVIDUALS: A CROSSOVER STUDY OF PLATELET FUNCTION TESTS AND GENOTYPIC VARIATION</a><div class="gs_gray">SL Fairley, F Kee, MF McMullin, M Stevenson, P McKeown</div><div class="gs_gray">Irish journal of medical science 179, S402-S402<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Differential expression of haemostasis system genes and prothrombotic cytokines in patients with myeloproliferative disorders</a><div class="gs_gray">L Kannan, MF McMullin, PC Winter</div><div class="gs_gray">ENDOCRINE JOURNAL 57, S589-S589<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">LIST OF REFEREES FOR 2009</a><div class="gs_gray">D Allan, K Armstrong, P Ball, G Briggs, B Campbell, MJ Campbell, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Familial erythrocytosis associated HIF-2αlpha mutations</a><div class="gs_gray">M Percy, P Furlow, P Beer, G Campbell, A Dekker, A Green, X Li, ...</div><div class="gs_gray">American Journal Of Hematology 84 (9)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Snippets in haematology</a><div class="gs_gray">S McCloskey, MF McMullin</div><div class="gs_gray">Journal of Clinical Pathology 62 (9), 858-861<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WC23djZS0W4C" class="gsc_a_at">EVALUATION OF THE PROTEASOMAL EFFECTS OF TYROSINE KINASE INHIBITORS AND BORTEZOMIB IN CHRONIC MYELOID LEUKAEMIA</a><div class="gs_gray">S McCloskey, MF McMullin, B Walker, A Irvine</div><div class="gs_gray">HAEMATOLOGICA 94, 125-125<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uLbwQdceFCQC" class="gsc_a_at">TYROSINE PHOSPHORYLATED SOCS3 IS UNABLE TO REGULATE THE MYELOPROLIFERATIVE NEOPLASM ASSOCIATED-JAK2 V617F KINASE</a><div class="gs_gray">J Elliott, Y Suessmuth, K Nahlik, M McMullin, S Constantinescu, ...</div><div class="gs_gray">HAEMATOLOGICA 94, 353-353<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">SOCS3 TYROSINE PHOSPHORYLATION AS A BIG-MARKER FOR THE MYELOPROLIFERATIVE DISORDER-ASSOCIATED MUTANT JAK2 KINASES</a><div class="gs_gray">K Nahlik, J Elliott, Y Suessmuth, LM Scott, MF McMullin, ...</div><div class="gs_gray">HAEMATOLOGICA 94, 358-358<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Snippets in surgical pathology</a><div class="gs_gray">S McCloskey, MF McMullin</div><div class="gs_gray">Journal of clinical pathology 62 (4), 380-383<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Safe and effective use of combination therapy with anagrelide and hydroxyurea in patients with chronic myeloproliferative disorders: 159</a><div class="gs_gray">K Adu, N Wiles, Y Francis, M McMullin, J Reilly, A Green, P Beer, D Radia, ...</div><div class="gs_gray">British Journal of Haematology 145, 64-65<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:VLnqNzywnoUC" class="gsc_a_at">A genetic disease in humans demonstrates the importance of hypoxia‐inducible factor in skeletal muscle metabolism</a><div class="gs_gray">F Formenti, K Clarke, KL Dorrington, L Edwards, Y Emmanuel, ...</div><div class="gs_gray">The FASEB Journal 23, 955.32-955.32<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tKAzc9rXhukC" class="gsc_a_at">A regional audit of essential thrombocythaemia: benefits, implications and future directions</a><div class="gs_gray">R Thompson, MF McMullin</div><div class="gs_gray">British Journal of Haematology 145, 69-69<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Erythropoietin synthesis is primarily regulated by the PHD2-HIF-2alpha-VHL axis as documented by HIF-2alpha associated familial erythrocytosis</a><div class="gs_gray">MJ Percy, PW Furlow, PA Beer, G Campbell, AW Dekker, AR Green, X Li, ...</div><div class="gs_gray">British Journal of Haematology 145, 44-45<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Tyrosine kinase and proteasome inhibition alter proteasome expression in BCR-ABL positive cell lines</a><div class="gs_gray">S McCloskey, MF McMullin, B Walker, A Irvine</div><div class="gs_gray">British Journal of Haematology 145, 21-22<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">11th Meeting of the Irish Society of Human Genetics, Friday 12th September 2008</a><div class="gs_gray">P Carty, J Kelly, S McCabe, N Coen, C Bermingham, T Morris, D Betts, ...</div><div class="gs_gray">The Ulster Medical Journal 78 (1), 65-74<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">DETECTION OF A 12P13 CHROMOSOME ANOMALY INVOLVING ETV6 AT RELAPSE IN AN ADOLESCENT PRESENTING WITH CYTOGENETICALLY NORMAL, FLT3-ITD+, TYPE A NPM1+ DE NOVO AML (M5 FAB-TYPE).</a><div class="gs_gray">P McGrattan, MW Humphreys, KI Mills, AF Gilkes, MF McMullin</div><div class="gs_gray">Ulster Medical Journal 78 (1)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">A'gain-of-function'mutation in the hypoxia-inducible 2α gene does not reduce exercise capacity in humans</a><div class="gs_gray">F Formenti, P Beer, QPP Croft, KL Dorrington, DP Gale, TRJ Lappin, ...</div><div class="gs_gray">Journal of physiological sciences, 357-357<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Chronic Myeloid Leukemia-Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation</a><div class="gs_gray">A Hayat, SR McCann, S Langabeer, S Irvine, MF McMullin, E Conneally</div><div class="gs_gray">Haematologica 94 (2), 296<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Article de périodique (Journal article)</a><div class="gs_gray">J Elliott, Y Suessmuth, LM Scott, K Nahlik, MF McMullin, S Constantinescu, ...</div><div class="gs_gray">haematologica 94 (4), 576-580<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5awf1xo2G04C" class="gsc_a_at">Ber-Abl Positive Cells Display Increased Proteasome Activity and Greater Sensitivity to Proteasome Inhibition</a><div class="gs_gray">L Crawford, P Windrum, L Magill, JV Melo, L McCallum, MF McMullin, ...</div><div class="gs_gray">Blood 112, 1095-1096<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Early Evaluation of a New Elearning and Online Video Lecture Course for Third Year Medical Students.</a><div class="gs_gray">K McGlade, J James, MF McMullin</div><div class="gs_gray">E-Learn: World Conference on E-Learning in Corporate, Government, Healthcare&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Bcr-Abl Positive Cells Display Increased Proteasome Activity and Greater Sensitivity to Proteasome Inhibition</a><div class="gs_gray">L Crawford, P Windrum, L Magill, JV Melo, L McCallum, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3192-3192<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">G‐CSF increases proteasome activity in myeloid cells</a><div class="gs_gray">SM McCloskey, P Windrum, MF McMullin, B Walker, AE Irvine</div><div class="gs_gray">British journal of haematology 143 (4), 598-601<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-jrNzM816MMC" class="gsc_a_at">FAMILIAL ERYTHROCYTOSIS ASSOCIATED WITH A MUTATIONAL HOTSPOT IN THE HIF2A GENE</a><div class="gs_gray">MJ Percy, PA Beer, G Campbell, AW Dekker, AR Green, D Oscier, ...</div><div class="gs_gray">HAEMATOLOGICA 93, 179-179<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Associations between methods of measurement of aspirin resistance and their temporal variations in patients with ischaemic heart disease</a><div class="gs_gray">AR Muir, MF McMullin, C Patterson, P McKeown</div><div class="gs_gray">Heart (British Cardiac Society) 94, A137-A137<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">THE ROLE OF C-FLIP IN ACUTE MYELOID LEUKEMIA</a><div class="gs_gray">DP McLoman, MF McMullin, KI Mills, PG Johnston, DB Longley</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93, 11-11<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:JP7YXuLIOvAC" class="gsc_a_at">Characterisation of HOXA6 in haematopoiesis and AML</a><div class="gs_gray">GJ McGonigle, D Finnegan, MF McMullin, K Mills, T Lappin, A Thompson</div><div class="gs_gray">British Journal of Haematology 141, 117-117<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Erythrocytosis associated with mutations in the active site of the prolyl hydroxylase PHD2</a><div class="gs_gray">MJ Percy, PW Furlow, Q Zhao, A Flores, C Harrison, PA Beer, T Lappin, ...</div><div class="gs_gray">British Journal of Haematology 141, 67-67<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Erythrocytosis with low serum Epo is commonly associated with JAK2 exon 12 gain of function mutations</a><div class="gs_gray">MJ Percy, LM Scott, WN Erber, CN Harrison, JT Reilly, FGC Jones, ...</div><div class="gs_gray">British Journal of Haematology 141, 68-69<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:P5F9QuxV20EC" class="gsc_a_at">G-CSF increases proteasome activity in myeloid cells</a><div class="gs_gray">MF Mcmullin, B Walker, AE Irvine</div><div class="gs_gray">proteins 274, 72-83<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Profiling the proteasome in BCR-ABL positive cell lines</a><div class="gs_gray">SM McCloskey, M McMullin, B Walker, A Irvine</div><div class="gs_gray">British Journal of Haematology 141, 44-45<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Analysis of HOXA5 and HOYB3 expression complements conventional cytogenetic analysis in acute myeloid leukemia</a><div class="gs_gray">DPJ Finnegan, VM Hodges, A Thompson, M Quinn, M Humphries, ...</div><div class="gs_gray">Blood 110, 705A-705A<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:anf4URPfarAC" class="gsc_a_at">A Novel HIFalpha Mutation Associated with Familial Erythrocytosis Supports This Isoform Being the Major Regulator of Erythropoietin in Humans.</a><div class="gs_gray">MJ Percy, PW Furlow, GS Lucas, X Li, TR Lappin, MF McMullin, FS Lee</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), LB5-LB5<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Analysis of <i>HOXA5</i> and <i>HOXB3</i> Expression Complements Conventional Cytogenetic Analysis in Acute Myeloid Leukemia.</a><div class="gs_gray">DPJ Finnegan, VM Hodges, A Thompson, MF Quinn, M Humphries, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 2388-2388<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Alternative splicing targets PBX3 mrna for nonsense mediated decay</a><div class="gs_gray">D Finnegan, VM Hodges, T Lappin, MF McMullin</div><div class="gs_gray">HAEMATOLOGICA 92, 419-419<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">CCN3: An additional marker for profiling response to imatinib?</a><div class="gs_gray">W Lu, L McCallum, S Price, R Frazer, MF McMullin, R Cuthbert, A Irvine</div><div class="gs_gray">HAEMATOLOGICA 92, 380-380<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:7H_MAutzIkAC" class="gsc_a_at">The myeloproliferative disease JAK2 V617F mutant cannot be regulated by SOCS proteins</a><div class="gs_gray">M Hookham, J Elliott, Y Suessmuth, A Ward, J Staerk, W Vainchenker, ...</div><div class="gs_gray">HAEMATOLOGICA 92, 86-86<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Artificial neural network analysis identifies novel patterns of HOX gene expression in prognostic subgroups of acute myeloid leukaemia</a><div class="gs_gray">DP Finnegan, M Quinn, M Humphreys, T Lappin, MF McMullin, ...</div><div class="gs_gray">British Journal of Haematology 137, 67-67<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hMod-77fHWUC" class="gsc_a_at">A survey of haematology teaching in UK and Irish medical schools</a><div class="gs_gray">MF McMullin, M Boohan</div><div class="gs_gray">British Journal of Haematology 137, 45-46<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:blknAaTinKkC" class="gsc_a_at">Investigation of HOXA6 as a candidate gene in AML</a><div class="gs_gray">GJ McGonigle, DPJ Finnegan, MF McMullin, T Lappin, A Thompson</div><div class="gs_gray">British Journal of Haematology 137, 38-39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Idiopathic erythrocytosis is associated with a risk of thrombosis-a retrospective case series review</a><div class="gs_gray">A Hodson, CN Harrison, M Percy, F Jones, MF McMullin</div><div class="gs_gray">British Journal of Haematology 137, 44-45<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Artificial Neural Network Analysis of HOX Gene Expression Profiles Predicts Prognostic Subgroups in Acute Myeloid Leukemia.</a><div class="gs_gray">DPJ Finnegan, MF Quinn, M Humphreys, TRJ Lappin, MF McMullin, ...</div><div class="gs_gray">Blood 108 (11), 2318<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Natural History of Idiopathic Erythrocytosis− A Retrospective Case Series Review.</a><div class="gs_gray">A Hodson, C Harrison, M Percy, F Jones, MF McMullin</div><div class="gs_gray">Blood 108 (11), 1298<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:DUooU5lO8OsC" class="gsc_a_at">The spectrum of molecular defects in idiopathic erythrocytosis</a><div class="gs_gray">MJ Percy, FGC Jones, T Lappin, MF McMullin</div><div class="gs_gray">British Journal of Haematology 133, 120-120<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">A novel mutation in the HIF prolyl hydroxylase, PHD2, associated with familial erythrocytosis</a><div class="gs_gray">MJ Percy, Q Zhao, A Floresw, C Harrisonz, T Lappin, PH Maxwell, ...</div><div class="gs_gray">British Journal of Haematology 133, 16-16<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Evaluation of three diagnostic criteria for polycythaemia vera</a><div class="gs_gray">EC Arnold, RC Turkington, MJ Percy, RJG Cuthbert, LA Ranaghan, ...</div><div class="gs_gray">British Journal of Haematology 133, 63-63<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:M7yex6snE4oC" class="gsc_a_at">Expression of NADH-cytochrome b (5) reductase variants provides important functional insights into recessive congenital methaemoglobinaemia</a><div class="gs_gray">MJ Percy, LJ Crowleyw, CA Davis, J Boudreaux, D Layton, MF McMullin, ...</div><div class="gs_gray">British Journal of Haematology 133, 71-71<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Beta-thalassaemia mutations in the northern Ireland population</a><div class="gs_gray">M Knott, KMA Ramadan, G Savage, FGC Jones, M El-Agnaf, MF McMullin, ...</div><div class="gs_gray">British Journal of Haematology 133, 72-72<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Cytokine stimulation increases proteasome activity</a><div class="gs_gray">P Windrum, MF McMullin, B Walker, A Irvine</div><div class="gs_gray">British Journal of Haematology 133, 77-77<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:AHdEip9mkN0C" class="gsc_a_at">A Novel Heterologous Expression System for Characterization of Individual NADH-Cytochrome <i>b</i><sub>5</sub> Reductase Variants in Recessive Congenital&nbsp;…</a><div class="gs_gray">MJ Percy, LJ Crowley, CA Davis, J Boudreaux, DM Layton, MF McMullin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1676-1676<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Type I methemoglobinemia arising due to a change in cofactor specificity of cytochrome B5 reductase</a><div class="gs_gray">MJ Percy, LJ Crowley, CA Davis, MF McMullin, G Savage, C McMahon, ...</div><div class="gs_gray">Experimental Hematology 33, 78-78<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Rapid genotyping for thiopurine methyltransferase polymorphisms in patients with acute leukaemia using lightcycler PCR</a><div class="gs_gray">MA Catherwood, JEA Davison, MF McMullin</div><div class="gs_gray">Experimental Hematology 33, 101-101<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:nZcligLrVowC" class="gsc_a_at">The novel D239G mutation in the NADH binding lobe of cytochrome b5 reductase affects its specificity for substrate: 221</a><div class="gs_gray">M PERCY, L CROWLEY, C DAVIS, M MCMULLIN, G Savage, J Hughes, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:hCrLmN-GePgC" class="gsc_a_at">The prevalence and clinical spectrum of paroxysmal nocturnal haemoglobinuria in Northern Ireland</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">British Journal of Haematology 129, 72-72<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">An overview of the clinical usage of the anti-CD20 monoclonal antibody rituximab at the regional haematology unit, Belfast City Hospital: 197</a><div class="gs_gray">G BENSON, R Cuthbert, M Drake, F Jones, P Kettle, M MCMULLIN, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Bcr-Abl kinase expression increases proteasome activity</a><div class="gs_gray">P Windrum, L Mccallum, B Walker, MF McMullin, A Irvine</div><div class="gs_gray">British Journal of Haematology 129, 80-81<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Papers to be published in forthcoming issues. Bone marrow architecture in acute myeloid/erythroid leukaemia. Leukemia–a developmental perspective. Guidelines for the use of&nbsp;…</a><div class="gs_gray">SM McCloskey, MF McMullin, TCM Morris, GM Markey, S Izraeli, ...</div><div class="gs_gray">British Journal of Haematology 125 (6), no-no<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">The Pro582Ser polymorphism in the VHL binding site of HIF-1 alpha is present in patients with idiopathic erythrocytosis but does not diminish binding to pVHL</a><div class="gs_gray">MJ Percy, SM Mooney, A Flores, MF McMullin, T Lappin, FS Lee</div><div class="gs_gray">British Journal of Haematology 125, 26-26<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:v1_lew4L6wgC" class="gsc_a_at">A novel mutation in the ALAS2 gene in a family with X-linked sideroblastic anaemia</a><div class="gs_gray">MJ Percy, A May, MF McMullin, R Cuthbert</div><div class="gs_gray">British Journal of Haematology 125, 26-26<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:u-coK7KVo8oC" class="gsc_a_at">The use of anagrelide for control of thrombocythaemia at the regional haematology unit, Belfast City Hospital</a><div class="gs_gray">G Benson, R Cuthbert, F Jones, P Kettle, M McMullin</div><div class="gs_gray">British Journal of Haematology-Supplement 125<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">The C598T VHL mutation arose in an ancestor common to Asian and Caucasian populations</a><div class="gs_gray">MJ Percy, E Liu, C Amos, SO Ang, N Cole, V Gordeuk, Y Guan, ...</div><div class="gs_gray">British Journal of Haematology 125, 25-25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NJ774b8OgUMC" class="gsc_a_at">The use of imatinib in the treatment of CML in patients over 65 years in Northern Ireland</a><div class="gs_gray">MF McMullin, M Humphreys, RJG Cuthbert</div><div class="gs_gray">British Journal of Haematology 125, 20-20<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Proteolytic activities of the proteasome in chronic myeloid leukaemia</a><div class="gs_gray">P Windrum, B Walker, MF McMullin, A Irvine</div><div class="gs_gray">British Journal of Haematology 125, 40-40<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Are we getting as much information as possible from bone marrow biopsies?</a><div class="gs_gray">KMA Ramadan, J Anderson, M Drake, MF McMullin, TCM Morris, P Kettle, ...</div><div class="gs_gray">British Journal of Haematology 125, 40-41<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">An unusual case of CML with an isodicentric Philadelphia chromosome and a poor response to imatanib</a><div class="gs_gray">A Logan, MF McMullin, MW Humphreys</div><div class="gs_gray">JOURNAL OF MEDICAL GENETICS 41, S54-S54<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">The worldwide distribution of the VHL 598C&gt; T mutation indicates a single founding mutation.</a><div class="gs_gray">E Liu, MJ Percy, C Amos, YL Guan, S Shete, MF McMullin, SO Ang, ...</div><div class="gs_gray">Blood 102, 204A-205A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">The Pro582Ser polymorphism in the VHL binding domain of HIF-1 alpha does not prevent its association with VHL nor play a role in erythrocytosis.</a><div class="gs_gray">MJ Percy, SM Mooney, MF McMullin, A Flores, T Lappin, FS Lee</div><div class="gs_gray">Blood 102, 503A-504A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:48xauSegjOkC" class="gsc_a_at">Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6</a><div class="gs_gray">M Quinn, MF McMullin, F Lopez, A Thompson, TR Lappin</div><div class="gs_gray">Experimental Hematology 31, 151-151<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">The use of imatinib in the treatment of CML in Northern Ireland</a><div class="gs_gray">M McMullin, M Humphreys, M Foley, R Cuthbert</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Recessive congenital ethaemoglobinaemia in five Irish families</a><div class="gs_gray">M Percy, M Gillespie, J Hughes, M McMullin, R Quinn, O Smith, T Lappin</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Global down-regulation of HOX gene expression in acute promyelocytic leukaemia identified by real-time PCR</a><div class="gs_gray">A Thompson, M Quinn, D Grimwade, M McMullin, F Cotter, T Lappin</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Chuvash-type congenital polycythaemia identified in four families of Asian and Western European ancestry</a><div class="gs_gray">M Percy, M McMullin, S Jowitt, M Potter, M Treacy, W Watson, T Lappin</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Autologous bone marrow transplantation for acute myeloid leukemia and concurrent granulocytic sarcoma: two case reports</a><div class="gs_gray">D Finnegan, F Jones, J Murdock, MF McMullin</div><div class="gs_gray">Bone Marrow Transplantation 31<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Identification of one English and four Asian families with Chuvash-type congenital polycythemia</a><div class="gs_gray">M Percy, M Mcmullin, S Jowitt, M Potter, S Thein, M Treacy, W Watson, ...</div><div class="gs_gray">Experimental Hematology 31 (7), 300<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">New annotation for an old observation: Two novel mutations revealed in original patients with familial idiopathic methemoglobin reductase deficiency.</a><div class="gs_gray">MJ Percy, MJS Gillespie, G Savage, A Hughes, MF McMullin, T Lappin</div><div class="gs_gray">Blood 100, 227A-227A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Altered HOX gene expression in acute promyelocytic leukemia.</a><div class="gs_gray">A Thompson, M Quinn, D Grimwade, CM O'Neill, MF McMullin, FE Cotter, ...</div><div class="gs_gray">Blood 100, 734A-734A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Two cases of CML with variant Philadelphia translocations</a><div class="gs_gray">M Humphreys, M Ryan, M McMullin</div><div class="gs_gray">JOURNAL OF MEDICAL GENETICS 39, S57-S57<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:q-HalDI95KYC" class="gsc_a_at">An assessment of spontaneous apoptosis, bcl-2 and bax during sepsis in acute myeloid leukaemia</a><div class="gs_gray">Y Ong, M McMullin, T Lappin, F Jones, A Irvine</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 58-59<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:rO6llkc54NcC" class="gsc_a_at">Regulation of a sub-set of HOX genes by ATRA in the Acute Promyelocytic Leukemia cell line, NB4</a><div class="gs_gray">C O'Neill, MF McMullin, T Lappin, A Thompson</div><div class="gs_gray">Experimental Hematology 30, 108-108<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">British Society for Haematology Slide Session, Annual Scientific Meeting, Bournemouth, 2000</a><div class="gs_gray">BJ Bain, D Swirsky, M Bhavnani, M Layton, N Parker, M Markis, ...</div><div class="gs_gray">Clinical and Laboratory Haematology 23 (4), 265-269<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Hepatosplenic Candidiasis, its Treatment and Effect on Remission Status in Patients with Acute Leukaemia—a Report of Five Cases</a><div class="gs_gray">JW Hamilton, MF McMullin, F Jones</div><div class="gs_gray">Hematology 6 (5), 331-335<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:BzfGm06jWhQC" class="gsc_a_at">IDIOPATHIC ERYTHROCYTOSIS: THE CLINICAL AND LABORATORY SPECTRUM</a><div class="gs_gray">M McMullin, F Jones, M Messinezy, T Pearson</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">The molecular basis of disorders of the red cell membrane (vol 52, pg 247, 1999)</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">JOURNAL OF CLINICAL PATHOLOGY 52 (5), 399-399<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Expression of interleukin 1 beta converting enzyme does not correlate with spontaneous intramedullary apoptosis.</a><div class="gs_gray">A Irvine, OM Buckley, MK Magill, MF McMullin</div><div class="gs_gray">British Journal of Haematology 105, 92-92<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:wKETBy42zhYC" class="gsc_a_at">Spontaneous apoptosis as a prognostic indicator in acute myeloid leukaemia.</a><div class="gs_gray">YL Ong, MF McMullin, F Jones, A Irvine</div><div class="gs_gray">British Journal of Haematology 105, 77-77<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Commentary: Early treatment is essential</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Bmj 319, 531-2<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:dhFuZR0502QC" class="gsc_a_at">SURVIVAL FROM ACUTE LEUKAEMIA IN PATIENTS OVER 55 YEARS IN N. IRELAND: A DISCRETE POPULATION</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Is excessive spontaneous intramedullary apoptosis unique to myelodysplasia?-Reply</a><div class="gs_gray">A Irvine, MF McMullin</div><div class="gs_gray">Experimental Hematology 26, 1016-1017<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Spontaneous intramedullary apoptosis is independent of caspase 1 expression.</a><div class="gs_gray">A Irvine, OM Buckley, MK Magill, MF McMullin</div><div class="gs_gray">Blood 92, 164B-165B<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Homocysteine and methylmalonic acid as indicators of folate and vitamin B-12 deficiency in pregnancy.</a><div class="gs_gray">MF McMullin, PB Young, KEM Baillie, T Lappin, R White</div><div class="gs_gray">Blood 92, 19B-19B<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis.</a><div class="gs_gray">MF McMullin, O Buckley, MK Magill, A Irvine</div><div class="gs_gray">Experimental Hematology 25, 452-452<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Investigation of the 3'hypoxia-responsive element of the human erythropoietin gene for sequence variations in patients with erythrocytosis</a><div class="gs_gray">MJ Percy, T Lappin, MF McMullin</div><div class="gs_gray">Experimental Hematology 25, 142-142<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:maZDTaKrznsC" class="gsc_a_at">Isolation of growth factor-independent retrovirally-infected tf-i cells</a><div class="gs_gray">MJ Percy, TRJ Lappin, PM Bucklev, MF McMullin</div><div class="gs_gray">Experimental Hematology 24 (9)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Growth factor-independent cell lines derived from retrovirally-infected TF-1 cells exhibit a selective block in erythropoietin-induced differentiation.</a><div class="gs_gray">MJ Percy, T Lappin, OM Buckley, MF McMullin</div><div class="gs_gray">Blood 88, 3168-3168<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Erythropoietin levels in pregnancy and relationships to haematinic levels.</a><div class="gs_gray">MF McMullin, T Lappin, SE Haggan, GA Savage, R White</div><div class="gs_gray">British Journal of Haematology 93, 324-324<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">'TUNEL'labelling of bone marrow from patients with haematological malignancies.</a><div class="gs_gray">A Irvine, MK Magill, E Macfarlane, MF McMullin</div><div class="gs_gray">Experimental Hematology 24, 739-739<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Prevention of Infection after Splenectomy</a><div class="gs_gray">MF McMullin</div><div class="gs_gray">Clinical Immunotherapeutics 3 (3), 191-195<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Screening for Erythropoietin Receptor Mutations in Patients with Myeloproliferative Disorders</a><div class="gs_gray">MJ Percy, PC Winter, TRJ Lappin, MF McMullin</div><div class="gs_gray">EXPERIMENTAL HEMATOLOGY-COPENHAGEN THEN EL PASO TEXAS THEN NEW YORK- 23, 84-84<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Erratum: Long term management of patients after splenectomy (BMJ, 27 November, p. 1372)</a><div class="gs_gray">M McMullin, G Johnston</div><div class="gs_gray">British Medical Journal 308 (6920)<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">lip,~ W</a><div class="gs_gray">G McElroy, B Smyth, PJMNC Nevin, JS Logan, A Finlay, MW Swallow, ...</div><div class="gs_gray">The Ulster Medical Journal 62 (2)<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:_5tno0g5mFcC" class="gsc_a_at">SERUM ERYTHROPOIETIN LEVELS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA</a><div class="gs_gray">MF MCMULLIN, E ELDER, P HILLMEN, L LUZZATTO</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 62-62<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">(D5) Haemopoiesis in long-term marrow culture as an indicator of early myelodysplasia</a><div class="gs_gray">MF McMullin, C Collett, IAG Reilly</div><div class="gs_gray">Leukemia Research 15, 8<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">BIOACTIVE AND IMMUNOREACTIVE SERUM ERYTHROPOIETIN-A COMPARISON OF THE MOUSE SPLEEN-CELL ASSAY AND A RADIOIMMUNOASSAY</a><div class="gs_gray">T Lappin, GE Elder, MF McMullin, T Taylor, J Bridges</div><div class="gs_gray">Experimental Hematology 16, 510-510<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">CONTROL OF ERYTHROPOIESIS IN ANEMIA-AN ANIMAL-MODEL</a><div class="gs_gray">MF MCMULLIN</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 66 (4), 576-576<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:Zph67rFs4hoC" class="gsc_a_at">ERYTHROPOIETIC RESPONSE TO ACUTE HYPOBARIC HYPOXIA IN THE RABBIT</a><div class="gs_gray">MF MCMULLIN, GE ELDER, TRJ LAPPIN, GA SAVAGE, JM BRIDGES</div><div class="gs_gray">EXPERIMENTAL HEMATOLOGY 14 (6), 484-484<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">RUXOLITINIB IN MYELOFIBROSIS</a><div class="gs_gray">J Russell, C Wright, D Sparksman, D Waddell, A Daly, R Fisken, A Dicu, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Haematological Malignancies Myeloproliferative Disorders</a><div class="gs_gray">MF McMullin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:0CzhzZyukY4C" class="gsc_a_at">SURVIVAL FROM ACUTE MYELOID LEUKAEMIA IN PATIENTS OVER 55 YEARS OF AGE IN NORTHERN IRELAND: A DISCRETE POPULATION.</a><div class="gs_gray">G MacKenzie, MF McMullin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Assessment of aspirin resistance varies on</a><div class="gs_gray">AR Muir, MF McMullin, C Patterson, PP McKeown</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Search Site</a><div class="gs_gray">MF McMullin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">RESEARCH ARTICLE AJH AJH</a><div class="gs_gray">GJ Titmarsh, AS Duncombe, MF McMullin, M O’Rorke, R Mesa, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Fine tuning treatment strategy to improve outcome in an imatinib resistant CML patient using conventional cytogenetic and ultra-deep sequencing technologies</a><div class="gs_gray">P McGrattan, MA Catherwood, S Lawless, N Robson, S Soverini, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">The Use of Erythropoiesis-Stimulating Agents With Ruxolitinib in Patients With Primary Myelofibrosis, Post–Polycythemia Vera Myelofibrosis, and Post–Essential Thrombocythemia&nbsp;…</a><div class="gs_gray">MF McMullin, CN Harrison, D Niederwieser, H Demuynck, N Jäkel, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:NhqRSupF_l8C" class="gsc_a_at">MUTATION UPDATE</a><div class="gs_gray">C Bento, MJ Percy, B Gardie, TM aes Maia, R van Wijk, S Perrotta, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">A novel mutation, Ile289Thr, in the ALAS2 gene in a family with X-linked sideroblastic anemia</a><div class="gs_gray">MJ Percy, A May, MF McMullin, RJG Cuthbert</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">A MULTICENTRE EXPERIENCE IN ENGLAND, NORTHERN IRELAND AND WALES</a><div class="gs_gray">J RUSSELL, A DALY, R FISKEN, A DICU, J CUNNINGHAM, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=beoArAkAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=beoArAkAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Primary Familial and Congenital Polycythemia Synonyms: ECYT1, Familial Erythrocytosis Type</a><div class="gs_gray">C Bento, MF McMullin, M Percy, H Cario</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–518</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>